The Roles of Serotonin in Neuropsychiatric Disorders
The serotonergic system extends throughout the central nervous system (CNS) and the gastrointestinal (GI) tract. In the CNS, serotonin (5-HT, 5-hydroxytryptamine) modulates a broad spectrum of functions, including mood, cognition, anxiety, learning, memory, reward processing, and sleep. These proces...
Saved in:
Published in | Cellular and molecular neurobiology Vol. 42; no. 6; pp. 1671 - 1692 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.08.2022
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0272-4340 1573-6830 1573-6830 |
DOI | 10.1007/s10571-021-01064-9 |
Cover
Abstract | The serotonergic system extends throughout the central nervous system (CNS) and the gastrointestinal (GI) tract. In the CNS, serotonin (5-HT, 5-hydroxytryptamine) modulates a broad spectrum of functions, including mood, cognition, anxiety, learning, memory, reward processing, and sleep. These processes are mediated through 5-HT binding to 5-HT receptors (5-HTRs), are classified into seven distinct groups. Deficits in the serotonergic system can result in various pathological conditions, particularly depression, schizophrenia, mood disorders, and autism. In this review, we outlined the complexity of serotonergic modulation of physiologic and pathologic processes. Moreover, we provided experimental and clinical evidence of 5-HT’s involvement in neuropsychiatric disorders and discussed the molecular mechanisms that underlie these illnesses and contribute to the new therapies. |
---|---|
AbstractList | The serotonergic system extends throughout the central nervous system (CNS) and the gastrointestinal (GI) tract. In the CNS, serotonin (5-HT, 5-hydroxytryptamine) modulates a broad spectrum of functions, including mood, cognition, anxiety, learning, memory, reward processing, and sleep. These processes are mediated through 5-HT binding to 5-HT receptors (5-HTRs), are classified into seven distinct groups. Deficits in the serotonergic system can result in various pathological conditions, particularly depression, schizophrenia, mood disorders, and autism. In this review, we outlined the complexity of serotonergic modulation of physiologic and pathologic processes. Moreover, we provided experimental and clinical evidence of 5-HT's involvement in neuropsychiatric disorders and discussed the molecular mechanisms that underlie these illnesses and contribute to the new therapies. The serotonergic system extends throughout the central nervous system (CNS) and the gastrointestinal (GI) tract. In the CNS, serotonin (5-HT, 5-hydroxytryptamine) modulates a broad spectrum of functions, including mood, cognition, anxiety, learning, memory, reward processing, and sleep. These processes are mediated through 5-HT binding to 5-HT receptors (5-HTRs), are classified into seven distinct groups. Deficits in the serotonergic system can result in various pathological conditions, particularly depression, schizophrenia, mood disorders, and autism. In this review, we outlined the complexity of serotonergic modulation of physiologic and pathologic processes. Moreover, we provided experimental and clinical evidence of 5-HT's involvement in neuropsychiatric disorders and discussed the molecular mechanisms that underlie these illnesses and contribute to the new therapies.The serotonergic system extends throughout the central nervous system (CNS) and the gastrointestinal (GI) tract. In the CNS, serotonin (5-HT, 5-hydroxytryptamine) modulates a broad spectrum of functions, including mood, cognition, anxiety, learning, memory, reward processing, and sleep. These processes are mediated through 5-HT binding to 5-HT receptors (5-HTRs), are classified into seven distinct groups. Deficits in the serotonergic system can result in various pathological conditions, particularly depression, schizophrenia, mood disorders, and autism. In this review, we outlined the complexity of serotonergic modulation of physiologic and pathologic processes. Moreover, we provided experimental and clinical evidence of 5-HT's involvement in neuropsychiatric disorders and discussed the molecular mechanisms that underlie these illnesses and contribute to the new therapies. |
Author | Ward, Richard Shahriari, Elahe Joghataei, Mohammad Taghi Pourhamzeh, Mahsa Ahadi, Reza Mehrabi, Soraya Moravej, Fahimeh Ghasemi Arabi, Mehrnoosh |
Author_xml | – sequence: 1 givenname: Mahsa orcidid: 0000-0002-6712-7220 surname: Pourhamzeh fullname: Pourhamzeh, Mahsa organization: Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences – sequence: 2 givenname: Fahimeh Ghasemi orcidid: 0000-0003-3878-3082 surname: Moravej fullname: Moravej, Fahimeh Ghasemi organization: Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences – sequence: 3 givenname: Mehrnoosh orcidid: 0000-0002-2867-7916 surname: Arabi fullname: Arabi, Mehrnoosh organization: Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Department of Radiology and Medical Physics, Faculty of Paramedicine, Kashan University of Medical Sciences – sequence: 4 givenname: Elahe orcidid: 0000-0002-1956-4354 surname: Shahriari fullname: Shahriari, Elahe organization: Faculty of Medicine, Department of Physiology, Iran University of Medical Sciences – sequence: 5 givenname: Soraya orcidid: 0000-0001-8555-726X surname: Mehrabi fullname: Mehrabi, Soraya organization: Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Faculty of Medicine, Department of Physiology, Iran University of Medical Sciences – sequence: 6 givenname: Richard orcidid: 0000-0002-9827-7889 surname: Ward fullname: Ward, Richard organization: Department of Psychology, University of Wisconsin–Milwaukee – sequence: 7 givenname: Reza orcidid: 0000-0002-3484-9606 surname: Ahadi fullname: Ahadi, Reza email: ahadi.r@iums.ac.ir organization: Department of Anatomy, Faculty of Medicine, Iran University of Medical Sciences – sequence: 8 givenname: Mohammad Taghi orcidid: 0000-0003-0492-8239 surname: Joghataei fullname: Joghataei, Mohammad Taghi email: joghataei.mt@iums.ac.ir organization: Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Department of Anatomy, Faculty of Medicine, Iran University of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33651238$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtvFDEQhC0URDaBP8ABjcSFy5BuP8bjE0LhKUUgQThbXm9P1tGsvdgzSPn3eLMhJDlEsuWDvypXu47YQUyRGHuJ8BYB9ElBUBpb4HUjdLI1T9gClRZt1ws4YAvgmrdSSDhkR6VcAoABUM_YoRCdQi76BZPna2p-pJFKk4bmJ-U0pRhiU9c3mnPaliu_Dm7KwTcfQkl5Rbk8Z08HNxZ6cXMes1-fPp6ffmnPvn_-evr-rPVK4tSaXnVeoOHc8UEKw3GlUAvCpZZOGCWE8T3SIDuz1FijeeJedwh8MH23cuKYvdv7buflhlae4pTdaLc5bFy-sskFe_8mhrW9SH8souSoJVSHNzcOOf2eqUx2E4qncXSR0lwsl0ZJqLSu6OsH6GWac6zzWd712EuD3FTq1d1It1n-_WgF-B7wOZWSabhFEOyuNruvzdba7HVtdufaPxD5MLkppN1YYXxcKvbSUt-JF5T_x35E9Rejsals |
CitedBy_id | crossref_primary_10_1093_brain_awae143 crossref_primary_10_1016_j_pharmthera_2023_108574 crossref_primary_10_2147_IJGM_S474525 crossref_primary_10_1016_j_envpol_2024_124370 crossref_primary_10_1016_j_fmre_2024_09_006 crossref_primary_10_3390_genes15091118 crossref_primary_10_3390_ijms25094845 crossref_primary_10_62347_GEEW4432 crossref_primary_10_3390_nu16040549 crossref_primary_10_1016_j_arr_2024_102537 crossref_primary_10_3389_fphar_2021_716338 crossref_primary_10_3389_fpsyt_2025_1532803 crossref_primary_10_31083_j_rcm2509343 crossref_primary_10_1038_s41598_023_51138_5 crossref_primary_10_1007_s12264_024_01304_0 crossref_primary_10_1039_D3AY00459G crossref_primary_10_3390_jcm12196353 crossref_primary_10_3389_fpsyt_2024_1309022 crossref_primary_10_3390_ijms231810624 crossref_primary_10_1002_cbic_202400837 crossref_primary_10_1007_s12035_021_02525_4 crossref_primary_10_3390_metabo13050629 crossref_primary_10_1016_j_talanta_2024_125808 crossref_primary_10_3390_ijms25126655 crossref_primary_10_1021_acs_jafc_4c08560 crossref_primary_10_1016_j_biopsych_2024_08_027 crossref_primary_10_1016_j_phrs_2024_107090 crossref_primary_10_3390_nu16244368 crossref_primary_10_1007_s00213_024_06629_2 crossref_primary_10_1109_OJEMB_2024_3356177 crossref_primary_10_1016_j_ijbiomac_2025_140956 crossref_primary_10_1038_s41597_024_03538_z crossref_primary_10_1515_revneuro_2023_0055 crossref_primary_10_1155_2023_5602401 crossref_primary_10_1016_j_jpsychires_2024_01_012 crossref_primary_10_1002_jdn_10354 crossref_primary_10_1016_j_cellsig_2024_111311 crossref_primary_10_1021_acs_jmedchem_2c00633 crossref_primary_10_3390_ijms251910329 crossref_primary_10_1038_s41598_024_81656_9 crossref_primary_10_1016_j_neuropharm_2024_109890 crossref_primary_10_4236_jbbs_2024_1412020 crossref_primary_10_1371_journal_pone_0304370 crossref_primary_10_18699_vjgb_24_46 crossref_primary_10_3389_fnut_2024_1337889 crossref_primary_10_1016_j_brainres_2024_149101 crossref_primary_10_1093_lifemeta_loae039 crossref_primary_10_3389_fmicb_2022_873555 crossref_primary_10_1186_s40246_024_00609_5 crossref_primary_10_3390_jcm12165231 crossref_primary_10_1016_j_carbon_2024_119550 crossref_primary_10_3390_brainsci12101286 crossref_primary_10_4103_1673_5374_377587 crossref_primary_10_1007_s11033_024_09514_5 crossref_primary_10_3390_nu16142228 crossref_primary_10_1007_s00253_023_12584_3 crossref_primary_10_1017_S0967199424000406 crossref_primary_10_1038_s41467_023_37246_w crossref_primary_10_1097_JCMA_0000000000001146 crossref_primary_10_1016_j_pnpbp_2024_111038 crossref_primary_10_1515_chem_2024_0088 crossref_primary_10_1016_j_heliyon_2024_e35363 crossref_primary_10_1091_mbc_E23_03_0117 crossref_primary_10_3390_ijms241914618 crossref_primary_10_1155_2022_4785077 crossref_primary_10_3390_bs12060196 crossref_primary_10_3390_ijms24065246 crossref_primary_10_1016_j_prp_2024_155102 crossref_primary_10_3389_fpsyt_2024_1436906 crossref_primary_10_1155_2024_9680180 crossref_primary_10_1016_j_bbr_2023_114399 crossref_primary_10_1016_j_ejphar_2024_176869 crossref_primary_10_20473_amnt_v7i2_2023_283_294 crossref_primary_10_1016_j_bbr_2023_114438 crossref_primary_10_7759_cureus_70728 crossref_primary_10_1016_j_jep_2024_118789 crossref_primary_10_1016_j_bbr_2024_115193 crossref_primary_10_1016_j_saa_2024_125541 crossref_primary_10_1002_jssc_70041 crossref_primary_10_1177_02698811221092509 crossref_primary_10_1093_intimm_dxae035 crossref_primary_10_3390_ijms242216416 crossref_primary_10_1002_jbt_23571 crossref_primary_10_1038_s41401_024_01252_5 crossref_primary_10_1016_j_jaac_2022_10_001 crossref_primary_10_1021_acs_jafc_3c03533 crossref_primary_10_1097_MD_0000000000035728 crossref_primary_10_1038_s41398_024_03216_z crossref_primary_10_1093_psyrad_kkae007 crossref_primary_10_1111_cns_70037 crossref_primary_10_3390_jpm12101719 crossref_primary_10_1177_12034754231204295 crossref_primary_10_3389_fnut_2023_1209613 crossref_primary_10_4236_psych_2024_1511100 crossref_primary_10_1016_j_brs_2025_01_025 crossref_primary_10_1177_02698811241227672 crossref_primary_10_1007_s44337_024_00114_7 crossref_primary_10_1038_s41598_023_44877_y crossref_primary_10_1186_s40104_023_00866_9 crossref_primary_10_3390_biom14081017 crossref_primary_10_1093_lambio_ovae065 crossref_primary_10_2174_1570159X21666230222092029 crossref_primary_10_1097_YIC_0000000000000488 crossref_primary_10_1016_j_addicn_2024_100187 crossref_primary_10_1038_s41598_022_16130_5 crossref_primary_10_1093_scan_nsad039 crossref_primary_10_1021_acs_jafc_4c03870 crossref_primary_10_3390_ijms252413446 crossref_primary_10_1038_s41386_024_01993_1 crossref_primary_10_1016_j_csbj_2024_10_011 crossref_primary_10_1212_WNL_0000000000210077 crossref_primary_10_1007_s10571_023_01320_0 crossref_primary_10_1016_j_isci_2025_112092 crossref_primary_10_1002_aur_3010 crossref_primary_10_1002_hsr2_2276 crossref_primary_10_1038_s41386_025_02080_9 crossref_primary_10_1016_j_fct_2022_113308 crossref_primary_10_1016_j_dmd_2025_100068 crossref_primary_10_3390_molecules28145373 crossref_primary_10_1186_s13148_023_01610_w crossref_primary_10_26442_20751753_2022_5_201703 crossref_primary_10_3389_fnins_2024_1493619 crossref_primary_10_1007_s11332_024_01287_5 crossref_primary_10_1080_13543784_2023_2291470 crossref_primary_10_1016_j_toxrep_2025_102001 crossref_primary_10_3390_ijms24032080 crossref_primary_10_1016_j_yfrne_2025_101175 crossref_primary_10_1016_j_bbi_2023_08_016 crossref_primary_10_1016_j_bios_2024_116743 crossref_primary_10_3389_fnins_2025_1525230 crossref_primary_10_3390_ani14040632 crossref_primary_10_1007_s11920_024_01527_y crossref_primary_10_1007_s00210_024_03323_0 crossref_primary_10_1007_s11011_024_01447_z crossref_primary_10_1186_s12974_024_03211_7 crossref_primary_10_1111_bph_16216 crossref_primary_10_1016_j_bbr_2023_114520 crossref_primary_10_1016_j_jaacop_2024_09_005 crossref_primary_10_1111_ejn_16262 crossref_primary_10_1080_14786419_2025_2453970 crossref_primary_10_32322_jhsm_1182204 crossref_primary_10_1038_s41380_024_02696_1 crossref_primary_10_1016_j_ejmech_2024_116615 crossref_primary_10_1016_j_biocel_2024_106663 crossref_primary_10_1155_2024_5537319 crossref_primary_10_1016_j_phrs_2024_107434 crossref_primary_10_1007_s40120_024_00691_w crossref_primary_10_1038_s42255_022_00696_5 crossref_primary_10_1038_s41380_024_02537_1 crossref_primary_10_1016_j_nbd_2023_106179 crossref_primary_10_1016_j_phymed_2025_156412 crossref_primary_10_1038_s44319_023_00036_y crossref_primary_10_1016_j_neulet_2024_138034 crossref_primary_10_1007_s12035_024_04314_1 crossref_primary_10_3390_molecules26102838 crossref_primary_10_1007_s40211_023_00466_z crossref_primary_10_1016_j_ejphar_2025_177419 crossref_primary_10_9758_cpn_2022_20_2_228 crossref_primary_10_1007_s00484_025_02855_1 crossref_primary_10_1002_1873_3468_15099 |
Cites_doi | 10.1016/j.ejphar.2004.03.063 10.1016/j.bbr.2008.02.027 10.1016/j.neulet.2011.07.036 10.1016/j.neuropharm.2019.107703 10.1016/j.tins.2010.05.005 10.1016/j.biopsych.2007.03.016 10.3390/molecules23082087 10.1016/j.bbr.2003.08.015 10.1016/j.neubiorev.2016.02.008 10.1097/FBP.0b013e3282ee2a91 10.1016/S2215-0366(17)30015-9 10.1016/j.pscychresns.2013.02.001 10.1098/rstb.2012.0109 10.1016/j.nbd.2013.11.010 10.1016/j.physbeh.2012.12.009 10.31887/DCNS.2017.19.2/bbandelow 10.1016/j.neuroscience.2013.05.050 10.1016/j.bja.2019.08.010 10.3389/fncel.2013.00076 10.1037/a0014592 10.1007/s00213-006-0543-8 10.1016/j.neuropharm.2016.01.035 10.1097/JAN.0000000000000250 10.7554/eLife.06346 10.1111/j.2042-7158.2011.01384.x 10.1093/pch/pxy109 10.1038/s41467-018-04840-2 10.1371/journal.pone.0227554 10.1016/j.biopsych.2006.11.023 10.1007/s10803-019-04120-y 10.1038/mp.2017.165 10.4103/1673-5374.264445 10.1073/pnas.1522754113 10.1111/head.13731 10.3389/fncel.2017.00139 10.1111/bph.13432 10.1016/j.pneurobio.2015.09.005 10.1002/aur.1317 10.1038/nrd4075 10.1016/j.neulet.2020.134783 10.1016/j.neuron.2012.03.017 10.1074/jbc.M113.522094 10.1002/hipo.10012 10.1192/bjp.bp.107.041186 10.1177/0269881113482531 10.1017/S146114571000012X 10.1016/j.nlm.2018.05.007 10.1016/j.neubiorev.2019.04.012 10.1098/rstb.2012.0536 10.7554/eLife.46464 10.1017/S1461145714000637 10.1016/j.neuropharm.2012.10.026 10.1038/nrn3746 10.1037/pha0000209 10.1176/appi.neuropsych.11080202 10.1101/lm.037317.114 10.1016/j.ctcp.2016.04.005 10.1016/j.neuron.2014.07.002 10.1017/S1461145712000740 10.1523/JNEUROSCI.1623-07.2007 10.1177/0269881118817384 10.1111/j.1365-2982.2009.01370.x 10.1016/j.neuropharm.2019.107931 10.1016/j.neuropharm.2018.03.005 10.1016/j.pnpbp.2015.12.004 10.1186/1744-8069-4-54 10.1016/j.nicl.2018.01.016 10.1017/S1092852918001013 10.9758/cpn.2014.12.3.196 10.1038/s41598-018-28702-5 10.1016/j.drugalcdep.2014.01.002 10.1002/cne.24044 10.1176/appi.ajp.161.4.739 10.1038/sj.bjp.0705290 10.3389/fnint.2013.00071 10.1007/s12079-018-0482-2 10.1016/j.tips.2007.10.009 10.1016/j.neuropharm.2013.07.003 10.1017/S1461145712000119 10.1056/NEJMoa1301449 10.1016/j.neuron.2008.06.023 10.1016/j.neubiorev.2016.03.001 10.1177/0333102416646760 10.1007/s12035-011-8214-0 10.2165/11635850-000000000-00000 10.1021/acschemneuro.8b00283 10.1523/JNEUROSCI.4733-12.2013 10.1016/j.neuropharm.2011.03.022 10.1016/j.lfs.2018.08.050 10.1016/j.neuropharm.2012.06.061 10.1177/1535370215596383 10.2174/1567205011666140812114715 10.1001/jamapsychiatry.2017.2432 10.1016/j.biopsych.2006.02.013 10.1016/j.eurpsy.2013.11.004 10.1016/j.neuron.2009.12.003 10.1159/000362803 10.1371/journal.pone.0179934 10.1016/s1734-1140(13)71062-4 10.1074/jbc.M602848200 10.1038/nrn2075 10.1007/s10540-005-2896-3 10.31887/DCNS.2018.20.3/dnaber 10.1002/ajmg.b.32766 10.1016/j.neuropharm.2020.107985 10.1016/j.biopsych.2006.05.022 10.1186/s10194-020-01138-x 10.1038/mp.2008.89 10.1016/j.neubiorev.2016.08.031 10.1007/s00213-018-4872-1 10.1016/j.biopsych.2006.05.015 10.1016/j.febslet.2015.05.054 10.1038/nn.4116 10.1038/srep12667 10.1097/00008571-200412000-00003 10.1038/sj.bjp.0705576 10.1007/s10578-010-0193-2 10.1038/nature19318 10.1111/bph.13071 10.3389/fphar.2015.00162 10.1038/s41386-020-0723-y 10.1097/FBP.0000000000000132 10.1038/s41386-018-0013-0 10.1016/j.expneurol.2019.113165 10.30773/pi.2018.12.21.1 10.2174/1567202613666160823164136 10.1016/j.neubiorev.2014.06.005 10.4088/jcp.v66n0312 10.1038/sj.mp.4001563 10.1016/j.brainresrev.2008.12.009 10.1016/j.bbr.2014.04.007 10.1016/j.biopsych.2005.02.028 10.1186/1824-7288-36-79 10.1016/j.eurpsy.2017.06.001 10.1007/s40263-013-0071-0 10.1016/s1734-1140(09)70132-x 10.1002/14651858 10.1523/JNEUROSCI.0941-12.2012 10.1016/j.bbr.2018.01.009 10.1001/jamapediatrics.2017.5227 10.1016/j.cca.2019.10.023 10.1093/ijnp/pyu034 10.1007/s10803-015-2646-8 10.1111/j.1469-8749.2008.03027.x 10.1001/archgenpsychiatry.2009.137 10.1176/appi.ajp.2011.10050764 10.1155/2019/1389296 10.1111/j.1526-4610.2006.00675.x 10.1208/aapsj070242 10.1093/brain/aws176 10.1016/j.bbr.2015.10.007 10.1016/j.biopsych.2006.11.005 10.1177/0269881115581093 10.1016/j.celrep.2014.12.033 10.1016/j.schres.2008.08.004 10.2174/138945009789735192 10.1016/S2215-0366(16)00012-2 10.1007/s00213-010-2097-z 10.1016/j.neuroscience.2011.09.036 10.1523/JNEUROSCI.5261-04.2005 10.1080/17470919.2015.1087875 10.1016/j.physbeh.2007.03.028 10.1007/s00213-007-0826-8 10.1016/j.brainres.2015.10.044 10.1080/17460441.2018.1394838 10.1016/j.neuroscience.2007.10.026 10.1038/sj.npp.1301509 10.1016/j.pnpbp.2013.04.009 10.1007/s11596-018-1912-3 10.2147/JPR.S132833 10.1080/01674820412331282231 10.1016/j.tins.2019.03.004 10.1016/j.neuroimage.2009.07.069 10.2174/1570159X15666170911121027 10.1016/j.bbapap.2011.02.008 10.1001/archgenpsychiatry.2009.30 10.3389/fphar.2019.00053 10.1002/jcp.29077 10.1523/JNEUROSCI.1020-13.2014 10.1111/apa.15077 10.1097/FBP.0b013e3282d28f9c 10.1007/s11055-007-0062-z 10.3389/fnins.2018.00982 10.1016/j.mehy.2013.03.013 10.1016/s1734-1140(10)70362-5 10.1016/j.biopsych.2007.06.024 10.1038/npp.2013.332 10.1038/s41398-018-0128-4 10.1016/j.bbr.2013.05.051 10.1038/npp.2011.13 10.1586/14737175.7.10.1357 10.1016/j.neuropharm.2013.12.006 10.1016/j.pnpbp.2012.04.008 10.1159/000363102 10.1096/fj.06-5724com 10.1113/JP273355 10.1038/s41392-019-0063-8 10.1001/jama.2019.14685 10.2165/11530240-000000000-00000 10.3389/fnbeh.2014.00453 10.1111/j.1476-5381.2012.01868.x 10.21037/tp.2019.10.02 10.1016/B978-0-12-800901-7.00009-4 10.1007/978-3-7091-6301-6_24 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 2021 |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 – notice: 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature. – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021. – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1007/s10571-021-01064-9 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1573-6830 |
EndPage | 1692 |
ExternalDocumentID | PMC11421740 33651238 10_1007_s10571_021_01064_9 |
Genre | Journal Article Review |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C -~X .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67N 67Z 6NX 78A 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAHNG AAIAL AAJKR AAJSJ AAKKN AANXM AANZL AARHV AARTL AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABEEZ ABFTV ABHLI ABHQN ABIVO ABJNI ABJOX ABKCH ABKTR ABMNI ABMOR ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACACY ACBXY ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACULB ACZOJ ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFGCZ AFGXO AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BGNMA C24 C6C CAG COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LLZTM M4Y MA- MVM N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P PF0 PT5 QOK QOR QOS R4E R89 R9I RHV RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TN5 TSG TSK TSV TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~A9 ~EX ~KM AAFWJ AASML AAYXX ABDBE ABFSG ACSTC ADHKG AEZWR AFHIU AGQPQ AHPBZ AHWEU AIXLP AYFIA CITATION RPM CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c541t-9856c31922a2f43921d5173e1b74a395339c81ef469b71900ce2c76102f986da3 |
IEDL.DBID | U2A |
ISSN | 0272-4340 1573-6830 |
IngestDate | Thu Aug 21 18:27:15 EDT 2025 Fri Jul 11 08:47:59 EDT 2025 Sat Sep 13 16:42:01 EDT 2025 Mon Jul 21 06:02:55 EDT 2025 Tue Jul 01 01:40:23 EDT 2025 Thu Apr 24 22:58:51 EDT 2025 Fri Feb 21 02:46:24 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | SSRI Serotonin pathway 5-HT Mood Disorders Nervous System Diseases |
Language | English |
License | 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c541t-9856c31922a2f43921d5173e1b74a395339c81ef469b71900ce2c76102f986da3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-9827-7889 0000-0001-8555-726X 0000-0002-3484-9606 0000-0003-3878-3082 0000-0003-0492-8239 0000-0002-1956-4354 0000-0002-2867-7916 0000-0002-6712-7220 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11421740 |
PMID | 33651238 |
PQID | 2681849129 |
PQPubID | 2043780 |
PageCount | 22 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11421740 proquest_miscellaneous_2495401427 proquest_journals_2681849129 pubmed_primary_33651238 crossref_primary_10_1007_s10571_021_01064_9 crossref_citationtrail_10_1007_s10571_021_01064_9 springer_journals_10_1007_s10571_021_01064_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-08-01 |
PublicationDateYYYYMMDD | 2022-08-01 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: Netherlands |
PublicationTitle | Cellular and molecular neurobiology |
PublicationTitleAbbrev | Cell Mol Neurobiol |
PublicationTitleAlternate | Cell Mol Neurobiol |
PublicationYear | 2022 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Baldo, Rose (CR10) 2020; 124 Curtin, Medan, Neumeister, Bronson, Preuss (CR42) 2013; 33 Mendez-David, David, Darcet, Wu, Kerdine-Römer, Gardier, Hen (CR128) 2014; 39 Westrich, Sprouse, Sánchez (CR199) 2013; 110 Jeong, Chenu, Johnson, Connor, Vaughan (CR94) 2008; 4 Speranza, Chambery, Di Domenico, Crispino, Severino, Volpicelli, Leopoldo, Bellenchi, Di Porzio, Perrone-Capano (CR176) 2013; 67 Karlsson, Tuominen, Huotarinen, Leppämäki, Sihvola, Helin, Sipilä, Tani, Hirvonen, Hietala, Karlsson (CR96) 2013; 212 Locher, Koechlin, Zion, Werner, Pine, Kirsch, Kessler, Kossowsky (CR115) 2017; 74 Sahu, Gopalakrishnan, Gaur, Chatterjee, Mol, Modi, Dagamajalu, Advani, Jain, Prasad (CR162) 2018; 12 Belmer, Quentin, Diaz, Guiard, Fernandez, Doly, Banas, Pitychoutis, Moutkine, Muzerelle, Tchenio (CR15) 2018; 43 Blier, El Mansari (CR20) 2013; 368 Wang, Zhang, Xu, Zhu, Wang, He, Zhang, Guo, Kong, Huang, Li (CR195) 2014; 11 Garcia-Garcia, Canetta, Stujenske, Burghardt, Ansorge, Dranovsky, Leonardo (CR66) 2018; 23 Bortolato, Godar, Tambaro, Li, Devoto, Coba, Chen, Shih (CR22) 2013; 75 Madsen, Torstensen, Holst, Haahr, Knorr, Frokjaer, Brandt-Larsen, Iversen, Fisher, Knudsen (CR119) 2015 Cruz, Eggan, Azmitia, Lewis (CR40) 2004; 161 Iigaya, Fonseca, Murakami, Mainen, Dayan (CR92) 2018; 9 King, Hollander, Sikich, McCracken, Scahill, Bregman, Donnelly, Anagnostou, Dukes, Sullivan, Hirtz (CR99) 2009; 66 Lin, Walther, Yu, Drgon, Uhl (CR111) 2004; 14 Żmudzka, Sałaciak, Sapa, Pytka (CR207) 2018; 210 Teissier, Soiza-Reilly, Gaspar (CR186) 2017; 11 Kudrow, Krege, Hundemer, Berg, Khanna, Ossipov, Pozo-Rosich (CR104) 2020; 60 Ohno, Shimizu, Tokudome, Kunisawa, Sasa (CR144) 2015; 134 Saitow, Hirono, Suzuki (CR163) 2012 Carr, Lucki (CR30) 2011; 213 Samuels, Anacker, Hu, Levinstein, Pickenhagen, Tsetsenis, Madroñal, Donaldson, Drew, Dranovsky, Gross (CR165) 2015; 18 Sghendo, Mifsud (CR170) 2012; 64 Huang, Ochandarena, Philson, Hyun, Birnbaum, Cicconet, Sabatini (CR89) 2019; 8 Tomaz de Magalhães, Núñez, Kato, Ribeiro (CR189) 2016; 241 Liu, Xie, Meng, Kang (CR114) 2019; 4 White, Walline, Barker (CR200) 2008; 7 Peña-Bautista, Flor, López-Nogueroles, García, Ferrer, Baquero, Vento, Cháfer-Pericás (CR149) 2020; 500 Nazeer, Latif, Mondal, Azeem, Greydanus (CR137) 2020; 9 Aparicio-Nava, Márquez-García, Meneses (CR6) 2019; 357 Trigo, Renoir, Lanfumey, Hamon, Lesch, Robledo, Maldonado (CR190) 2007; 62 CR131 Matsumoto, Ichise, Ito, Ando, Takahashi, Ikoma, Kosaka, Arakawa, Fujimura, Ota, Takano (CR125) 2010; 49 Jacobsen, Medvedev, Caron (CR93) 2012; 367 Akhondzadeh, Mohammadi, Noroozian, Karamghadiri, Ghoreishi, Jamshidi, Forghani (CR3) 2009; 107 Ohmura, Tanaka, Tsunematsu, Yamanaka, Yoshioka (CR142) 2014; 17 Stahl (CR177) 2018; 23 Rebello, Yu, Goodfellow, Cagliostro, Teissier, Morelli, Demireva, Chemiakine, Rosoklija, Dwork, Lambe (CR156) 2014; 34 George, Ameli, Koob (CR69) 2019; 42 Eggers (CR53) 2013; 80 Pauls, Abramovitch, Rauch, Geller (CR147) 2014; 15 Wang, Yu, Fu, Yeh, Hsu, Yang, Chen, Chiang, Pan (CR196) 2018; 8 Hollander, Soorya, Chaplin, Anagnostou, Taylor, Ferretti, Wasserman, Swanson, Settipani (CR82) 2012; 169 McCorvy, Harland, Maglathlin, Nichols (CR126) 2011; 505 Richardson-Jones, Craige, Guiard, Stephen, Metzger, Kung, Gardier, Dranovsky, David, Beck, Hen (CR159) 2010; 65 Nic Dhonnchadha, Fox, Stutz, Rice, Cunningham (CR47) 2009; 123 Kiryanova, Dyck (CR101) 2014; 36 Li, Li, Han, Wang, Yang, Wang, Tian (CR108) 2019; 10 Ruf, Bhagwagar (CR160) 2009; 10 Shilyansky, Williams, Gyurak, Harris, Usherwood, Etkin (CR173) 2016; 3 Herscu, Handen, Arnold, Snape, Bregman, Ginsberg, Hendren, Kolevzon, Melmed, Mintz, Minshew (CR81) 2019 Pallanti, Bernardi, Antonini, Singh, Hollander (CR146) 2009; 23 Jorgensen (CR95) 2007; 54 Lin, Lee, Yang (CR110) 2014; 12 Gonzalez, Chávez-Pascacio, Meneses (CR70) 2013; 252 Müller, Wiborg, Haase (CR133) 2006; 281 Burnett, Grant, Davenport, Hemby, Friedman (CR26) 2014; 136 Askari, Moin, Sanati, Tajdini, Modabbernia, Najand, Salimi, Tabrizi, Ashrafi, Hajiaghaee, Akhondzadeh (CR7) 2012; 26 Tamminga, Holcomb (CR182) 2005; 10 Dalva, McClelland, Kayser (CR43) 2007; 8 Frankle, Lombardo, Kegeles, Slifstein, Martin, Huang, Hwang, Reich, Cangiano, Gil, Laruelle (CR64) 2006; 189 Gupta, Thangaraj, Radhakrishnan (CR73) 2016; 297 Shelton, Yun, Losee Olson, Turek, Bonaventure, Dvorak, Lovenberg, Dugovic (CR172) 2015; 8 Tiger, Varnäs, Okubo, Lundberg (CR188) 2018; 235 Maleki, Samini, Babapour, Mehr, Cheraghiyan, Nouri (CR121) 2008; 190 Negro, Koverech, Martelletti (CR138) 2018; 11 Segelcke, Messlinger (CR167) 2017; 37 Naber, Bullinger (CR134) 2018; 20 Mnie-Filali, Faure, Lambás-Señas, El Mansari, Belblidia, Gondard, Etiévant, Scarna, Didier, Berod, Blier (CR130) 2011; 36 Blazevic, Horvaticek, Kesic, Zill, Hranilovic, Ivanisevic, Desoye, Stefulj (CR19) 2017; 12 Blattner, Canney, Pippin, Blass (CR18) 2018; 10 Burghardt, Bush, McEwen, LeDoux (CR25) 2007; 62 Duman, Monteggia (CR52) 2006; 59 Oblak, Gibbs, Blatt (CR141) 2013; 6 Falsone, Leitinger, Karner, Kungl, Kosol, Cappai, Zangger (CR58) 1814; 5 Hou, Xiong, Gu, Huang, Wang, Wu (CR85) 2018; 38 Linley, Olucha-Bordonau, Vertes (CR112) 2017; 525 Cleare, Pariante, Young, Anderson, Christmas, Cowen, Dickens, Ferrier, Geddes, Gilbody, Haddad (CR34) 2015; 29 Kawahara, Kawahara, Kaneko, Tanaka (CR97) 2007; 194 Cowen, Sherwood (CR39) 2013; 27 Tao, Wang, Wei, Traub, Li, Cao (CR184) 2019; 2019 Dölen (CR49) 2015; 10 Sengupta, Mickle, Kannampalli, Spruell, McRorie, Shaker, Miranda (CR169) 2014; 79 Reddihough, Marraffa, Mouti, O’Sullivan, Lee, Orsini, Hazell, Granich, Whitehouse, Wray, Dossetor (CR157) 2019; 322 Lorman (CR116) 2018; 29 Van Goethem, Schreiber, Newman-Tancredi, Varney, Prickaerts (CR192) 2015; 172 Volle, Bregman, Scott, Diwan, Raymond, Fletcher, Nobrega, Hamani (CR193) 2018; 135 Yamashita, Rosa, Lowry, Zangrossi (CR203) 2019; 33 Valluzzi, Chan (CR191) 2007; 18 Bélanger, Andrews, Gray, Korczak (CR14) 2018; 23 Makkonen, Riikonen, Kokki, Airaksinen, Kuikka (CR120) 2008; 50 Palazzo, Genovese, Mariani, Siniscalco, Marabese, de Novellis, Rossi, Maione (CR145) 2004; 492 Mdawar, Ghossoub, Khoury (CR127) 2020; 15 Begenisic, Baroncelli, Sansevero, Milanese, Bonifacino, Bonanno, Cioni, Maffei, Sale (CR13) 2014; 63 CR27 Hritcu, Clicinschi, Nabeshima (CR86) 2007; 91 Cummings, Leiter (CR37) 2020; 326 Lanzenberger, Mitterhauser, Spindelegger, Wadsak, Klein, Mien, Holik, Attarbaschi, Mossaheb, Sacher, Geiss-Granadia (CR105) 2007; 61 Zhao, Chiechio, Sun, Zhang, Zhao, Scott, Johnson, Deneris, Renner, Gereau, Chen (CR206) 2007; 27 Dold, Aigner, Lanzenberger, Kasper (CR48) 2013; 16 Gupta, Prabhakar, Radhakrishnan (CR72) 2016; 64 Collins, France (CR36) 2018; 26 Hviid, Melbye, Pasternak (CR90) 2013; 369 Williams, Brignell, Randall, Silove, Hazell (CR201) 2013 Fijał, Pachuta, McCreary, Wydra, Nowak, Papp, Bieńkowski, Kotlińska, Filip (CR61) 2010; 62 Davari-Ashtiani, Shahrbabaki, Razjouyan, Amini, Mazhabdar (CR45) 2010; 41 Marcinkiewcz, Mazzone, D’Agostino, Halladay, Hardaway, DiBerto, Navarro, Burnham, Cristiano, Dorrier, Tipton (CR122) 2016; 537 Martín-Cora, Pazos (CR124) 2004; 141 Cortes-Altamirano, Olmos-Hernandez, Jaime, Carrillo-Mora, Bandala, Reyes-Long, Alfaro-Rodríguez (CR38) 2018; 16 Lissemore, Sookman, Gravel, Berney, Barsoum, Diksic, Nordahl, Pinard, Sibon, Cottraux, Leyton (CR113) 2018; 8 Nakamura, Sekine, Ouchi, Tsujii, Yoshikawa, Futatsubashi, Tsuchiya, Sugihara, Iwata, Suzuki, Matsuzaki (CR135) 2010; 67 Celada, Bortolozzi, Artigas (CR31) 2013; 27 Garduño, Galindo-Charles, Jiménez-Rodríguez, Galarraga, Tapia, Mihailescu, Hernandez-Lopez (CR67) 2012; 32 Heinricher, Tavares, Leith, Lumb (CR80) 2009; 60 Xiang, Zhao, Li, Zheng, Wang, Li (CR202) 2016; 13 Aznar, Mel-S (CR9) 2016; 64 Eriksson, Holst, Stan, Hager, Sjögren, Ögren, Svenningsson, Stiedl (CR56) 2012; 63 Hamati, El Mansari, Blier (CR74) 2020 Barkas, Redhead, Taylor, Shtaya, Hamilton, Gray (CR12) 2012; 135 Kirby, Zeeb, Winstanley (CR100) 2011; 61 Lima, Abner, Sluka (CR109) 2017; 595 Chen, Ye, Gargus, Blakely, Dobrenis, Sze (CR32) 2015; 10 Li, Luikart, Birnbaum, Chen, Kwon, Kernie, Bassel-Duby, Parada (CR107) 2008; 59 Andalib, Emamhadi, Yousefzadeh-Chabok, Shakouri, Høilund-Carlsen, Vafaee, Michel (CR4) 2017; 45 Paulus, Mintz (CR148) 2016; 1630 Tatara, Shimizu, Shin, Sato, Sugiuchi, Imaki, Ohno (CR185) 2012; 38 Andreetta, Carboni, Grafton, Jeggo, Whyment, Van Den Top, Hoyer, Spanswick, Barnes (CR5) 2016; 173 Iidaka, Ozaki, Matsumoto, Nogawa, Kinoshita, Suzuki, Iwata, Yamamoto, Okada, Sadato (CR91) 2005; 25 Atmaca (CR8) 2016; 70 Han, Dai, Dong (CR76) 2015 Beversdorf, Nordgren, Bonab, Fischman, Weise, Dougherty, Felopulos, Zhou, Bauman (CR16) 2012; 24 CR205 Marler, Ferguson, Lee, Peters, Williams, McDonnell, Macklin, Levitt, Gillespie, Anderson, Margolis (CR123) 2016; 46 Provenzi, Fumagalli, Scotto di Minico, Giorda, Morandi, Sirgiovanni, Schiavolin, Mosca, Borgatti, Montirosso (CR152) 2020; 109 Field, Diego, Hernandez-Reif, Schanberg, Kuhn (CR59) 2004; 25 Dorocic, Fürth, Xuan, Johansson, Pozzi, Silberberg, Carlén, Meletis (CR50) 2014; 83 Raab, Kirsch, Mier (CR155) 2016; 71 Sharp, Boothman, Raley, Quérée (CR171) 2007; 28 Popova, Naumenko, Plyusnina (CR151) 2007; 37 Griebel, Holmes (CR71) 2013; 12 Lamiay, Schneider, Loric, Prada, Kellermann (CR106) 2006; 20 Lugo-Candelas, Cha, Hong, Bastidas, Weissman, Fifer, Myers, Talati, Bansal, Peterson, Monk (CR117) 2018; 172 Sano, Mishima, Koushi, Orito, Egashira, Irie, Takasaki, Katsurabayashi, Iwasaki, Uchida, Egawa (CR166) 2008; 151 Bandelow, Michaelis, Wedekind (CR11) 2017; 19 Abela, Browne, Sargin, Prevot, Ji, Li, Lambe, Fletcher (CR1) 2020; 15 Miszkiel, Przegaliński (CR129) 2013; 65 Adayev, Ranasinghe, Banerjee (CR2) 2005; 25 Müller, Homberg (CR132) 2015; 277 Puig, Gulledge (CR153) 2011; 44 Riccio, Potter, Walzer, Vallet, Szabo, Vutskits, Kiss, Dayer (CR158) 2009; 14 Selvaraj, Arnone, Cappai, Howes (CR168) 2014; 45 Deen, Hansen, Hougaard, Nørgaard, Eiberg, Lehel, Ashina, Knudsen (CR46) 2018; 18 Wesołowska, Nikiforuk, Stachowicz (CR198) 2007; 18 Burghardt, Bauer (CR24) 2013; 247 Hou, Xing, Li, Wang, Deng, Li, Zhang, Chen (CR84) 2020; 21 Hamon, Blier, Psychiatr J Garduño (1064_CR67) 2012; 32 DS Reddihough (1064_CR157) 2019; 322 F Saitow (1064_CR163) 2012 F Saitow (1064_CR164) 2020; 165 RD Oades (1064_CR140) 2007; 7 MB Dalva (1064_CR43) 2007; 8 J Miszkiel (1064_CR129) 2013; 65 PS Yamashita (1064_CR203) 2019; 33 BA Samuels (1064_CR165) 2015; 18 R Silva (1064_CR174) 2004; 151 A Oblak (1064_CR141) 2013; 6 S Akhondzadeh (1064_CR3) 2009; 107 T Begenisic (1064_CR13) 2014; 63 WG Frankle (1064_CR65) 2005; 57 SD Geddes (1064_CR68) 2016; 113 J Volle (1064_CR193) 2018; 135 KJ Cummings (1064_CR37) 2020; 326 ZQ Zhao (1064_CR206) 2007; 27 O Stiedl (1064_CR179) 2015; 6 D Kudrow (1064_CR104) 2020; 60 DL Pauls (1064_CR147) 2014; 15 D Gupta (1064_CR73) 2016; 297 M Hou (1064_CR84) 2020; 21 Y Ohmura (1064_CR142) 2014; 17 NK Popova (1064_CR151) 2007; 37 M Engel (1064_CR55) 2013; 7 I Mendez-David (1064_CR128) 2014; 39 P Herscu (1064_CR81) 2019 A Tatara (1064_CR185) 2012; 38 A Nikiforuk (1064_CR139) 2016; 105 NP Van Goethem (1064_CR192) 2015; 172 N Askari (1064_CR7) 2012; 26 S Blazevic (1064_CR19) 2017; 12 D Keszthelyi (1064_CR98) 2009; 21 SB Linley (1064_CR112) 2017; 525 KJ White (1064_CR200) 2008; 7 HS Jorgensen (1064_CR95) 2007; 54 FJ Martín-Cora (1064_CR124) 2004; 141 V Kiryanova (1064_CR101) 2014; 36 L Provenzi (1064_CR152) 2020; 109 D Gupta (1064_CR72) 2016; 64 SH Lin (1064_CR110) 2014; 12 L Sghendo (1064_CR170) 2012; 64 DT George (1064_CR69) 2019; 42 R Hamati (1064_CR74) 2020 A Wesołowska (1064_CR198) 2007; 18 GA Fava (1064_CR57) 2014; 83 1064_CR205 JR Nash (1064_CR136) 2008; 193 DM Cannon (1064_CR28) 2007; 62 AL Garcia-Garcia (1064_CR66) 2018; 23 A Nazeer (1064_CR137) 2020; 9 M Watabe-Uchida (1064_CR197) 2012; 74 LG Kirby (1064_CR100) 2011; 61 S Aznar (1064_CR9) 2016; 64 T Field (1064_CR60) 2016; 24 T Adayev (1064_CR2) 2005; 25 A Negro (1064_CR138) 2018; 11 DA Cruz (1064_CR40) 2004; 161 CA Marcinkiewcz (1064_CR122) 2016; 537 J Wang (1064_CR195) 2014; 11 A Cleare (1064_CR34) 2015; 29 JN Sengupta (1064_CR169) 2014; 79 K Nakamura (1064_CR135) 2010; 67 R El-Merahbi (1064_CR54) 2015; 589 Y Ohmura (1064_CR143) 2020; 167 T Sharp (1064_CR171) 2007; 28 I Makkonen (1064_CR120) 2008; 50 PC Curtin (1064_CR42) 2013; 33 HK Müller (1064_CR133) 2006; 281 D Segelcke (1064_CR167) 2017; 37 EJ Burnett (1064_CR26) 2014; 136 TJ Rebello (1064_CR156) 2014; 34 M Tiger (1064_CR188) 2018; 235 G Griebel (1064_CR71) 2013; 12 WJ Lorman (1064_CR116) 2018; 29 S Selvaraj (1064_CR168) 2014; 45 R Gonzalez (1064_CR70) 2013; 252 CJ Harmer (1064_CR78) 2017; 4 SA Bélanger (1064_CR14) 2018; 23 P Blier (1064_CR20) 2013; 368 YW Hou (1064_CR85) 2018; 38 F Andreetta (1064_CR5) 2016; 173 KW Huang (1064_CR89) 2019; 8 GV Carr (1064_CR30) 2011; 213 GJ Dölen (1064_CR49) 2015; 10 JA Valluzzi (1064_CR191) 2007; 18 GT Collins (1064_CR36) 2018; 26 A Pietrelli (1064_CR150) 2018; 155 SM Stahl (1064_CR177) 2018; 23 JP Jacobsen (1064_CR93) 2012; 367 PP Liu (1064_CR114) 2019; 4 CP Müller (1064_CR132) 2015; 277 JM Trigo (1064_CR190) 2007; 62 E Palazzo (1064_CR145) 2004; 492 JL Cortes-Altamirano (1064_CR38) 2018; 16 M Atmaca (1064_CR8) 2016; 70 A Belmer (1064_CR15) 2018; 43 1064_CR131 A Sahu (1064_CR162) 2018; 12 L Karlsson (1064_CR96) 2013; 212 M Dold (1064_CR48) 2013; 16 S Andalib (1064_CR4) 2017; 45 SA Maleki (1064_CR121) 2008; 190 M Bortolato (1064_CR22) 2013; 75 B Mdawar (1064_CR127) 2020; 15 K Xiang (1064_CR202) 2016; 13 L Hritcu (1064_CR86) 2007; 91 C Lugo-Candelas (1064_CR117) 2018; 172 K Fijał (1064_CR61) 2010; 62 K Sano (1064_CR166) 2008; 151 JD McCorvy (1064_CR126) 2011; 505 NS Burghardt (1064_CR24) 2013; 247 K Iigaya (1064_CR92) 2018; 9 FD Zepf (1064_CR204) 2010; 13 P Cowen (1064_CR39) 2013; 27 BH King (1064_CR99) 2009; 66 Y Li (1064_CR107) 2008; 59 R Matsumoto (1064_CR125) 2010; 49 O Riccio (1064_CR158) 2009; 14 NS Burghardt (1064_CR25) 2007; 62 AE Eggers (1064_CR53) 2013; 80 EA Daubert (1064_CR44) 2010; 33 H Tanaka (1064_CR183) 2020; 721 K Williams (1064_CR201) 2013 AR Abela (1064_CR1) 2020; 15 ZY Tao (1064_CR184) 2019; 2019 BM Ruf (1064_CR160) 2009; 10 C Peña-Bautista (1064_CR149) 2020; 500 LJ Wang (1064_CR196) 2018; 8 MV Puig (1064_CR153) 2011; 44 N Li (1064_CR108) 2019; 10 SF Falsone (1064_CR58) 1814; 5 J Shelton (1064_CR172) 2015; 8 M Cano-Colino (1064_CR29) 2013; 7 1064_CR27 CA Bolaños (1064_CR21) 2008; 63 E Hollander (1064_CR82) 2012; 169 T Iidaka (1064_CR91) 2005; 25 LM Koran (1064_CR103) 2005; 66 Y Kawahara (1064_CR97) 2007; 194 M Luo (1064_CR118) 2015; 22 MM Heinricher (1064_CR80) 2009; 60 S Marler (1064_CR123) 2016; 46 DR Thomas (1064_CR187) 2003; 139 BA Baldo (1064_CR10) 2020; 124 K Madsen (1064_CR119) 2015 L Aparicio-Nava (1064_CR6) 2019; 357 L Speranza (1064_CR176) 2013; 67 DQ Beversdorf (1064_CR16) 2012; 24 1064_CR175 C Shilyansky (1064_CR173) 2016; 3 CA Tamminga (1064_CR182) 2005; 10 P Curatolo (1064_CR41) 2010; 36 D Naber (1064_CR134) 2018; 20 E Żmudzka (1064_CR207) 2018; 210 T Takumi (1064_CR181) 2020; 110 RS Duman (1064_CR52) 2006; 59 WG Frankle (1064_CR64) 2006; 189 JY Cohen (1064_CR35) 2015; 4 PC Hsieh (1064_CR88) 2014; 29 JI Lissemore (1064_CR113) 2018; 8 H Han (1064_CR76) 2015 M Hołuj (1064_CR83) 2015; 26 A Hviid (1064_CR90) 2013; 369 TM Eriksson (1064_CR56) 2012; 63 H Takahashi (1064_CR180) 2002; 12 A Teissier (1064_CR186) 2017; 11 HJ Jeong (1064_CR94) 2008; 4 S Pallanti (1064_CR146) 2009; 23 M Tomaz de Magalhães (1064_CR189) 2016; 241 M Bostancıklıoğlu (1064_CR23) 2020; 235 Z Lin (1064_CR111) 2004; 14 K Raab (1064_CR155) 2016; 71 RR Lanzenberger (1064_CR105) 2007; 61 CC Wang (1064_CR194) 2014; 289 R Hargreaves (1064_CR77) 2007; 47 P Celada (1064_CR31) 2013; 27 LV Lima (1064_CR109) 2017; 595 BA Nic Dhonnchadha (1064_CR47) 2009; 123 E Quentin (1064_CR154) 2018; 12 P Stępnicki (1064_CR178) 2018; 23 M Hamon (1064_CR75) 2013; 45 MT Klein (1064_CR102) 2012; 166 L Westrich (1064_CR199) 2013; 110 C Locher (1064_CR115) 2017; 74 EV Paulus (1064_CR148) 2016; 1630 KM Blattner (1064_CR18) 2018; 10 M Filip (1064_CR62) 2009; 61 Y Ohno (1064_CR144) 2015; 134 JM Lamiay (1064_CR106) 2006; 20 B Bandelow (1064_CR11) 2017; 19 X Chen (1064_CR32) 2015; 10 T Field (1064_CR59) 2004; 25 JW Richardson-Jones (1064_CR159) 2010; 65 R Davari-Ashtiani (1064_CR45) 2010; 41 L Barkas (1064_CR12) 2012; 135 J He (1064_CR79) 2020; 15 IP Dorocic (1064_CR50) 2014; 83 O Mnie-Filali (1064_CR130) 2011; 36 PJ Fletcher (1064_CR63) 2008; 33 E Dremencov (1064_CR51) 2007; 61 MM Zugliani (1064_CR208) 2019; 16 M Deen (1064_CR46) 2018; 18 K Hrovatin (1064_CR87) 2020; 183 C Blanco (1064_CR17) 2013; 16 ZT Sahli (1064_CR161) 2018; 13 CM Ciarleglio (1064_CR33) 2011; 197 |
References_xml | – volume: 492 start-page: 169 issue: 2–3 year: 2004 end-page: 176 ident: CR145 article-title: Metabotropic glutamate receptor 5 and dorsal raphe serotonin release in inflammatory pain in rat publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2004.03.063 – volume: 190 start-page: 189 year: 2008 end-page: 192 ident: CR121 article-title: Potentiation of morphine-induced conditioned place preference with concurrent use of amantadine and fluvoxamine by the intraperitoneal and intracerebroventricular injection in rat publication-title: Behav Brain Res doi: 10.1016/j.bbr.2008.02.027 – volume: 505 start-page: 10 year: 2011 end-page: 13 ident: CR126 article-title: A 5-HT2C receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference publication-title: Neurosci Lett doi: 10.1016/j.neulet.2011.07.036 – volume: 167 start-page: 107703 year: 2020 ident: CR143 article-title: Different roles of distinct serotonergic pathways in anxiety-like behavior, antidepressant-like, and anti-impulsive effects publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2019.107703 – volume: 33 start-page: 424 year: 2010 end-page: 434 ident: CR44 article-title: Serotonin: a regulator of neuronal morphology and circuitry publication-title: Trends Neurosci doi: 10.1016/j.tins.2010.05.005 – volume: 62 start-page: 870 year: 2007 end-page: 877 ident: CR28 article-title: Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C] DASB; comparison with bipolar disorder publication-title: Psychiatry doi: 10.1016/j.biopsych.2007.03.016 – volume: 23 start-page: 2087 year: 2018 ident: CR178 article-title: Current concepts and treatments of schizophrenia publication-title: Molecules doi: 10.3390/molecules23082087 – volume: 151 start-page: 93 year: 2004 end-page: 101 ident: CR174 article-title: Differential regulation of the expression of contextual freezing and fear-potentiated startle by 5-HT mechanisms of the median raphe nucleus publication-title: Behav Brain Res doi: 10.1016/j.bbr.2003.08.015 – volume: 64 start-page: 63 year: 2016 end-page: 82 ident: CR9 article-title: The 5-HT2A serotonin receptor in executive function: implications for neuropsychiatric and neurodegenerative diseases publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2016.02.008 – volume: 18 start-page: 507 year: 2007 end-page: 513 ident: CR191 article-title: Effects of fluoxetine on hippocampal-dependent and hippocampal-independent learning tasks publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e3282ee2a91 – volume: 4 start-page: 409 year: 2017 end-page: 418 ident: CR78 article-title: How do antidepressants work? New perspectives for refining future treatment approaches publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(17)30015-9 – volume: 212 start-page: 164 year: 2013 end-page: 165 ident: CR96 article-title: Serotonin transporter in attention-deficit hyperactivity disorder–preliminary results from a positron emission tomography study publication-title: Psychiatry Res doi: 10.1016/j.pscychresns.2013.02.001 – volume: 367 start-page: 2444 year: 2012 end-page: 2459 ident: CR93 article-title: The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2012.0109 – volume: 63 start-page: 12 year: 2014 end-page: 19 ident: CR13 article-title: Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2013.11.010 – volume: 110 start-page: 42 year: 2013 end-page: 50 ident: CR199 article-title: The effects of combining serotonin reuptake inhibition and 5-HT7 receptor blockade on circadian rhythm regulation in rodents publication-title: Physiol Behav doi: 10.1016/j.physbeh.2012.12.009 – volume: 19 start-page: 93 year: 2017 end-page: 107 ident: CR11 article-title: Treatment of anxiety disorders publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2017.19.2/bbandelow – volume: 247 start-page: 253 year: 2013 end-page: 272 ident: CR24 article-title: Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits publication-title: Neuroscience doi: 10.1016/j.neuroscience.2013.05.050 – volume: 124 start-page: 44 year: 2020 end-page: 62 ident: CR10 article-title: The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review publication-title: Br J Anaesth doi: 10.1016/j.bja.2019.08.010 – volume: 7 start-page: 76 year: 2013 ident: CR55 article-title: The serotonin 5-HT3 receptor: a novel neurodevelopmental target publication-title: Front Cell Neurosci doi: 10.3389/fncel.2013.00076 – volume: 123 start-page: 382 issue: 2 year: 2009 end-page: 396 ident: CR47 article-title: Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model publication-title: Behav Neurosci doi: 10.1037/a0014592 – volume: 189 start-page: 155 year: 2006 ident: CR64 article-title: Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11 C] WAY 100635 publication-title: Psychopharmacology doi: 10.1007/s00213-006-0543-8 – volume: 105 start-page: 351 year: 2016 end-page: 360 ident: CR139 article-title: The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2016.01.035 – volume: 29 start-page: 260 year: 2018 end-page: 261 ident: CR116 article-title: Pharmacology Update: The Selective Serotonin Reuptake Inhibitors publication-title: J Addict Nurs doi: 10.1097/JAN.0000000000000250 – volume: 4 start-page: e06346 year: 2015 ident: CR35 article-title: Serotonergic neurons signal reward and punishment on multiple timescales publication-title: Elife doi: 10.7554/eLife.06346 – volume: 64 start-page: 317 year: 2012 end-page: 325 ident: CR170 article-title: Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model publication-title: J Pharm Pharmacol doi: 10.1111/j.2042-7158.2011.01384.x – volume: 23 start-page: 447 year: 2018 end-page: 453 ident: CR14 article-title: ADHD in children and youth: Part 1—Etiology, diagnosis, and comorbidity publication-title: Paediatr Child Health doi: 10.1093/pch/pxy109 – volume: 9 start-page: 1 year: 2018 end-page: 10 ident: CR92 article-title: An effect of serotonergic stimulation on learning rates for rewards apparent after long intertrial intervals publication-title: Nat Commun doi: 10.1038/s41467-018-04840-2 – volume: 15 start-page: e0227554 issue: 1 year: 2020 ident: CR79 article-title: Serotonin transporter dependent modulation of food-seeking behavior publication-title: PLoS ONE doi: 10.1371/journal.pone.0227554 – volume: 62 start-page: 1111 year: 2007 end-page: 1118 ident: CR25 article-title: Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT2C receptor antagonist publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.11.023 – year: 2019 ident: CR81 article-title: The SOFIA Study: negative multi-center study of low dose fluoxetine on repetitive behaviors in children and adolescents with autistic disorder publication-title: J Autism Dev Disord doi: 10.1007/s10803-019-04120-y – ident: CR27 – volume: 23 start-page: 1990 issue: 10 year: 2018 end-page: 1997 ident: CR66 article-title: Serotonin inputs to the dorsal BNST modulate anxiety in a 5-HT 1A receptor-dependent manner publication-title: Mol Psychiatry doi: 10.1038/mp.2017.165 – start-page: 915 year: 2012 end-page: 926 ident: CR163 publication-title: Serotonin and synaptic transmission in the cerebellum – volume: 15 start-page: 41 issue: 1 year: 2020 ident: CR127 article-title: Selective serotonin reuptake inhibitors and Alzheimer’s disease publication-title: Neural Regen Res doi: 10.4103/1673-5374.264445 – volume: 113 start-page: 5429 issue: 19 year: 2016 end-page: 5434 ident: CR68 article-title: Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1522754113 – volume: 60 start-page: 576 issue: 3 year: 2020 end-page: 588 ident: CR104 article-title: Issues impacting adverse event frequency and severity: differences between randomized phase 2 and phase 3 clinical trials for Lasmiditan publication-title: Headache doi: 10.1111/head.13731 – volume: 11 start-page: 139 year: 2017 ident: CR186 article-title: Refining the role of 5-HT in postnatal development of brain circuits publication-title: Front Cell Neurosci doi: 10.3389/fncel.2017.00139 – volume: 173 start-page: 1438 year: 2016 end-page: 1451 ident: CR5 article-title: Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo publication-title: Pharmacol doi: 10.1111/bph.13432 – volume: 134 start-page: 104 year: 2015 end-page: 121 ident: CR144 article-title: New insight into the therapeutic role of the serotonergic system in Parkinson's disease publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2015.09.005 – volume: 6 start-page: 571 year: 2013 end-page: 583 ident: CR141 article-title: Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism publication-title: Autism Res doi: 10.1002/aur.1317 – volume: 12 start-page: 667 issue: 9 year: 2013 end-page: 687 ident: CR71 article-title: 50 years of hurdles and hope in anxiolytic drug discovery publication-title: Nat Rev Drug Discov doi: 10.1038/nrd4075 – volume: 721 start-page: 134783 year: 2020 ident: CR183 article-title: Serotonin induces Arcadlin in hippocampal neurons publication-title: Neurosci Lett doi: 10.1016/j.neulet.2020.134783 – volume: 74 start-page: 858 issue: 5 year: 2012 end-page: 873 ident: CR197 article-title: Whole-brain mapping of direct inputs to midbrain dopamine neurons publication-title: Neuron doi: 10.1016/j.neuron.2012.03.017 – volume: 289 start-page: 8252 year: 2014 end-page: 8263 ident: CR194 article-title: Serotonin receptor 6 mediates defective brain development in monoamine oxidase A-deficient mouse embryos publication-title: J Biol Chem doi: 10.1074/jbc.M113.522094 – volume: 12 start-page: 304 year: 2002 end-page: 310 ident: CR180 article-title: 5-HT4 receptors in the hippocampus modulate rat locomotor activity publication-title: Hippocampus doi: 10.1002/hipo.10012 – volume: 193 start-page: 229 year: 2008 end-page: 234 ident: CR136 article-title: Serotonin 5-HT 1A receptor binding in people with panic disorder: positron emission tomography study publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.107.041186 – volume: 27 start-page: 575 year: 2013 end-page: 583 ident: CR39 article-title: The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression publication-title: J Psychopharmacol doi: 10.1177/0269881113482531 – volume: 13 start-page: 933 year: 2010 end-page: 941 ident: CR204 article-title: Serotonergic neurotransmission and lapses of attention in children and adolescents with attention deficit hyperactivity disorder: availability of tryptophan influences attentional performance publication-title: Neuropsychopharmacol doi: 10.1017/S146114571000012X – volume: 155 start-page: 528 year: 2018 end-page: 542 ident: CR150 article-title: Aerobic exercise upregulates the BDNF-Serotonin systems and improves the cognitive function in rats publication-title: Neurobiol Learn Mem doi: 10.1016/j.nlm.2018.05.007 – volume: 110 start-page: 60 year: 2020 end-page: 76 ident: CR181 article-title: Behavioral neuroscience of autism publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2019.04.012 – volume: 368 start-page: 20120536 issue: 1615 year: 2013 ident: CR20 article-title: Serotonin and beyond: therapeutics for major depression publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2012.0536 – volume: 8 start-page: e46464 year: 2019 ident: CR89 article-title: Molecular and anatomical organization of the dorsal raphe nucleus publication-title: Elife doi: 10.7554/eLife.46464 – volume: 17 start-page: 1777 year: 2014 end-page: 1783 ident: CR142 article-title: Optogenetic activation of serotonergic neurons enhances anxiety-like behaviour in mice publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145714000637 – volume: 67 start-page: 155 year: 2013 end-page: 167 ident: CR176 article-title: The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.10.026 – volume: 15 start-page: 410 year: 2014 end-page: 424 ident: CR147 article-title: Obsessive–compulsive disorder: an integrative genetic and neurobiological perspective publication-title: Nat Rev Neurosci doi: 10.1038/nrn3746 – volume: 26 start-page: 488 issue: 5 year: 2018 end-page: 496 ident: CR36 article-title: Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys publication-title: Exp Clin Psychopharmacol doi: 10.1037/pha0000209 – volume: 24 start-page: 191 year: 2012 end-page: 197 ident: CR16 article-title: 5-HT2 receptor distribution shown by [18F] setoperone PET in high-functioning autistic adults publication-title: J Neuropsychiatry Clin Neurosci doi: 10.1176/appi.neuropsych.11080202 – volume: 22 start-page: 452 year: 2015 end-page: 460 ident: CR118 article-title: (2015) Reward processing by the dorsal raphe nucleus: 5-HT and beyond publication-title: Learn Mem doi: 10.1101/lm.037317.114 – volume: 24 start-page: 19 year: 2016 end-page: 31 ident: CR60 article-title: Massage therapy research review publication-title: Complement Ther Clin Pract doi: 10.1016/j.ctcp.2016.04.005 – volume: 83 start-page: 663 issue: 3 year: 2014 end-page: 678 ident: CR50 article-title: A whole-brain atlas of inputs to serotonergic neurons of the dorsal and median raphe nuclei publication-title: Neuron doi: 10.1016/j.neuron.2014.07.002 – volume: 16 start-page: 557 issue: 3 year: 2013 end-page: 574 ident: CR48 article-title: Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145712000740 – volume: 27 start-page: 6045 issue: 22 year: 2007 end-page: 6053 ident: CR206 article-title: Mice lacking central serotonergic neurons show enhanced inflammatory pain and an impaired analgesic response to antidepressant drugs publication-title: Journal of J Neurosci doi: 10.1523/JNEUROSCI.1623-07.2007 – volume: 33 start-page: 3 issue: 1 year: 2019 end-page: 11 ident: CR203 article-title: Serotonin actions within the prelimbic cortex induce anxiolysis mediated by serotonin 1a receptors publication-title: Psychopharmacol doi: 10.1177/0269881118817384 – volume: 21 start-page: 1239 issue: 12 year: 2009 end-page: 1249 ident: CR98 article-title: Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function publication-title: Neurogastroenterol Motil doi: 10.1111/j.1365-2982.2009.01370.x – volume: 165 start-page: 107931 year: 2020 ident: CR164 article-title: Change in serotonergic modulation contributes to the synaptic imbalance of neuronal circuit at the prefrontal cortex in the 15q11–13 duplication mouse model of autism publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2019.107931 – volume: 135 start-page: 63 year: 2018 end-page: 72 ident: CR193 article-title: Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic system publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2018.03.005 – volume: 70 start-page: 127 year: 2016 end-page: 133 ident: CR8 article-title: Treatment-refractory obsessive compulsive disorder publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2015.12.004 – volume: 4 start-page: 1744 year: 2008 end-page: 8069 ident: CR94 article-title: Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey publication-title: Mol Pain doi: 10.1186/1744-8069-4-54 – volume: 18 start-page: 97 year: 2018 end-page: 102 ident: CR46 article-title: High brain serotonin levels in migraine between attacks: a 5-HT4 receptor binding PET study publication-title: Neuroimage Clin doi: 10.1016/j.nicl.2018.01.016 – volume: 23 start-page: 187 issue: 3 year: 2018 end-page: 191 ident: CR177 article-title: Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate publication-title: CNS Spectr doi: 10.1017/S1092852918001013 – volume: 12 start-page: 196 year: 2014 ident: CR110 article-title: Serotonin and mental disorders: a concise review on molecular neuroimaging evidence publication-title: Clin Psychopharmacol Neurosci doi: 10.9758/cpn.2014.12.3.196 – volume: 8 start-page: 1 issue: 1 year: 2018 end-page: 7 ident: CR196 article-title: Attention deficit–hyperactivity disorder is associated with allergic symptoms and low levels of hemoglobin and serotonin publication-title: Sci Rep doi: 10.1038/s41598-018-28702-5 – volume: 136 start-page: 135 year: 2014 end-page: 142 ident: CR26 article-title: The effects of chronic ethanol self-administration on hippocampal 5-HT1A receptors in monkeys publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2014.01.002 – volume: 525 start-page: 116 year: 2017 end-page: 139 ident: CR112 article-title: Pattern of distribution of serotonergic fibers to the amygdala and extended amygdala in the rat publication-title: J Comp Neurol doi: 10.1002/cne.24044 – volume: 54 start-page: 266 year: 2007 end-page: 288 ident: CR95 article-title: Studies on the neuroendocrine role of serotonin publication-title: Dan Med Bull – volume: 161 start-page: 739 issue: 4 year: 2004 end-page: 742 ident: CR40 article-title: Serotonin1A receptors at the axon initial segment of prefrontal pyramidal neurons in schizophrenia publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.161.4.739 – volume: 139 start-page: 705 year: 2003 end-page: 714 ident: CR187 article-title: SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0705290 – volume: 7 start-page: 71 year: 2013 ident: CR29 article-title: Serotonergic modulation of spatial working memory: predictions from a computational network model publication-title: Front Integr Neurosci doi: 10.3389/fnint.2013.00071 – volume: 12 start-page: 731 year: 2018 end-page: 735 ident: CR162 article-title: The 5-Hydroxytryptamine signaling map: an overview of serotonin-serotonin receptor mediated signaling network publication-title: J Cell Commun Signal doi: 10.1007/s12079-018-0482-2 – volume: 28 start-page: 629 year: 2007 end-page: 636 ident: CR171 article-title: Important messages in the ‘post’: recent discoveries in 5-HT neurone feedback control publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2007.10.009 – volume: 75 start-page: 223 year: 2013 end-page: 232 ident: CR22 article-title: Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.07.003 – volume: 16 start-page: 235 year: 2013 end-page: 249 ident: CR17 article-title: The evidence-based pharmacotherapy of social anxiety disorder publication-title: Neuropsychopharmacol doi: 10.1017/S1461145712000119 – volume: 369 start-page: 2406 issue: 25 year: 2013 end-page: 2415 ident: CR90 article-title: Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism publication-title: N Engl J Med doi: 10.1056/NEJMoa1301449 – volume: 59 start-page: 399 year: 2008 end-page: 412 ident: CR107 article-title: TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment publication-title: Neuron doi: 10.1016/j.neuron.2008.06.023 – volume: 64 start-page: 311 year: 2016 end-page: 325 ident: CR72 article-title: 5HT3 receptors: Target for new antidepressant drugs publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2016.03.001 – volume: 37 start-page: 365 issue: 4 year: 2017 end-page: 371 ident: CR167 article-title: Putative role of 5-HT2B receptors in migraine pathophysiology publication-title: Cephalalgia doi: 10.1177/0333102416646760 – volume: 44 start-page: 449 year: 2011 end-page: 464 ident: CR153 article-title: Serotonin and prefrontal cortex function: neurons, networks, and circuits publication-title: Mol Neurobiol doi: 10.1007/s12035-011-8214-0 – volume: 26 start-page: 883 issue: 10 year: 2012 end-page: 892 ident: CR7 article-title: Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder publication-title: CNS Drugs doi: 10.2165/11635850-000000000-00000 – volume: 10 start-page: 89 year: 2018 end-page: 119 ident: CR18 article-title: Pharmacology and Therapeutic Potential of the 5-HT7 Receptor publication-title: ACS Chem Neurosci doi: 10.1021/acschemneuro.8b00283 – volume: 33 start-page: 10011 year: 2013 end-page: 10020 ident: CR42 article-title: The 5-HT5A receptor regulates excitability in the auditory startle circuit: functional implications for sensorimotor gating publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4733-12.2013 – volume: 61 start-page: 421 year: 2011 end-page: 432 ident: CR100 article-title: Contributions of serotonin in addiction vulnerability publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2011.03.022 – volume: 210 start-page: 106 year: 2018 end-page: 124 ident: CR207 article-title: Serotonin receptors in depression and anxiety: Insights from animal studies publication-title: Life Sci. doi: 10.1016/j.lfs.2018.08.050 – volume: 63 start-page: 1150 year: 2012 end-page: 1160 ident: CR56 article-title: 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.06.061 – volume: 241 start-page: 40 issue: 1 year: 2016 end-page: 45 ident: CR189 article-title: Light therapy modulates serotonin levels and blood flow in women with headache publication-title: A preliminary study Exp Biol Med doi: 10.1177/1535370215596383 – volume: 11 start-page: 672 year: 2014 end-page: 680 ident: CR195 article-title: Fluoxetine improves behavioral performance by suppressing the production of soluble β-amyloid in APP/PS1 mice publication-title: Curr Alzheimer Res doi: 10.2174/1567205011666140812114715 – volume: 74 start-page: 1011 year: 2017 end-page: 1020 ident: CR115 article-title: Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2017.2432 – volume: 59 start-page: 1116 year: 2006 end-page: 1127 ident: CR52 article-title: A neurotrophic model for stress-related mood disorders publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.02.013 – volume: 29 start-page: 414 year: 2014 end-page: 418 ident: CR88 article-title: Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder–a preliminary two-ligand SPECT study publication-title: Eur Psychiatry doi: 10.1016/j.eurpsy.2013.11.004 – volume: 65 start-page: 40 year: 2010 end-page: 52 ident: CR159 article-title: 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants publication-title: Neuron doi: 10.1016/j.neuron.2009.12.003 – volume: 83 start-page: 197 issue: 4 year: 2014 end-page: 204 ident: CR57 article-title: Rational use of antidepressant drugs publication-title: Psychother Psychosom doi: 10.1159/000362803 – volume: 12 start-page: e0179934 issue: 6 year: 2017 ident: CR19 article-title: Epigenetic adaptation of the placental serotonin transporter gene (SLC6A4) to gestational diabetes mellitus publication-title: PLoS ONE doi: 10.1371/journal.pone.0179934 – volume: 65 start-page: 813 year: 2013 end-page: 822 ident: CR129 article-title: Effects of serotonin (5-HT) 1B receptor ligands on amphetamine-seeking behavior in rats publication-title: Pharmacol Rep doi: 10.1016/s1734-1140(13)71062-4 – volume: 281 start-page: 28901 year: 2006 end-page: 28909 ident: CR133 article-title: Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2 publication-title: J Biol Chem doi: 10.1074/jbc.M602848200 – volume: 8 start-page: 206 year: 2007 end-page: 220 ident: CR43 article-title: Cell adhesion molecules: signalling functions at the synapse publication-title: Nat Rev Neurosci doi: 10.1038/nrn2075 – volume: 25 start-page: 363 year: 2005 end-page: 385 ident: CR2 article-title: Transmembrane signaling in the brain by serotonin, a key regulator of physiology and emotion publication-title: Biosci Rep doi: 10.1007/s10540-005-2896-3 – volume: 20 start-page: 223 year: 2018 ident: CR134 article-title: Should antidepressants be used in minor depression? publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2018.20.3/dnaber – volume: 183 start-page: 113 issue: 2 year: 2020 end-page: 127 ident: CR87 article-title: Genetic variability of serotonin pathway associated with schizophrenia onset, progression, and treatment publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.32766 – volume: 15 start-page: 107985 issue: 168 year: 2020 ident: CR1 article-title: Median raphe serotonin neurons promote anxiety-like behavior via inputs to the dorsal hippocampus publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2020.107985 – volume: 61 start-page: 1081 year: 2007 end-page: 1089 ident: CR105 article-title: Reduced serotonin-1A receptor binding in social anxiety disorder publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.05.022 – volume: 21 start-page: 1 issue: 1 year: 2020 end-page: 12 ident: CR84 article-title: Short-term efficacy and safety of lasmiditan, a novel 5-HT 1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis publication-title: J Headache Pain doi: 10.1186/s10194-020-01138-x – volume: 14 start-page: 280 issue: 3 year: 2009 end-page: 290 ident: CR158 article-title: Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6 publication-title: Mol Psychiatry doi: 10.1038/mp.2008.89 – volume: 71 start-page: 176 year: 2016 end-page: 197 ident: CR155 article-title: Understanding the impact of 5-HTTLPR, antidepressants, and acute tryptophan depletion on brain activation during facial emotion processing: A review of the imaging literature publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2016.08.031 – volume: 235 start-page: 1317 issue: 5 year: 2018 end-page: 1334 ident: CR188 article-title: The 5-HT 1B receptor-a potential target for antidepressant treatment publication-title: Psychopharmacology doi: 10.1007/s00213-018-4872-1 – volume: 61 start-page: 671 issue: 5 year: 2007 end-page: 678 ident: CR51 article-title: Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.05.015 – volume: 589 start-page: 1728 year: 2015 end-page: 1734 ident: CR54 article-title: The roles of peripheral serotonin in metabolic homeostasis publication-title: FEBS Lett doi: 10.1016/j.febslet.2015.05.054 – volume: 18 start-page: 1606 year: 2015 ident: CR165 article-title: 5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response publication-title: Nat Neurosci doi: 10.1038/nn.4116 – year: 2015 ident: CR76 article-title: Single fluoxetine treatment before but not after stress prevents stress-induced hippocampal long-term depression and spatial memory retrieval impairment in rats publication-title: Sci Rep doi: 10.1038/srep12667 – volume: 14 start-page: 805 issue: 12 year: 2004 end-page: 811 ident: CR111 article-title: The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse publication-title: Pharmacogenetics doi: 10.1097/00008571-200412000-00003 – volume: 141 start-page: 92 year: 2004 end-page: 104 ident: CR124 article-title: Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H] mesulergine: comparison to other mammalian species publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0705576 – volume: 41 start-page: 641 year: 2010 end-page: 648 ident: CR45 article-title: Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial publication-title: Child Psychiatry Hum Dev doi: 10.1007/s10578-010-0193-2 – volume: 537 start-page: 97 year: 2016 end-page: 101 ident: CR122 article-title: Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala publication-title: Nature doi: 10.1038/nature19318 – volume: 172 start-page: 2532 issue: 10 year: 2015 end-page: 2543 ident: CR192 article-title: Divergent effects of the ‘biased’5-HT 1 A receptor agonists F15599 and F13714 in a novel object pattern separation task publication-title: Br J Pharmacol doi: 10.1111/bph.13071 – volume: 6 start-page: 162 year: 2015 ident: CR179 article-title: The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory publication-title: Front Pharmacol doi: 10.3389/fphar.2015.00162 – year: 2020 ident: CR74 article-title: Serotonin-2B receptor antagonism increases the activity of dopamine and glutamate neurons in the presence of selective serotonin reuptake inhibition publication-title: Neuropsychopharmacology doi: 10.1038/s41386-020-0723-y – volume: 26 start-page: 766 year: 2015 end-page: 775 ident: CR83 article-title: Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors publication-title: Behav Pharmacol doi: 10.1097/FBP.0000000000000132 – volume: 43 start-page: 1623 issue: 7 year: 2018 end-page: 1632 ident: CR15 article-title: Positive regulation of raphe serotonin neurons by serotonin 2B receptors publication-title: Neuropsychopharmacology doi: 10.1038/s41386-018-0013-0 – volume: 326 start-page: 113165 year: 2020 ident: CR37 article-title: Take a deep breath and wake up: The protean role of serotonin preventing sudden death in infancy publication-title: Exp Neurol doi: 10.1016/j.expneurol.2019.113165 – volume: 16 start-page: 50 issue: 1 year: 2019 end-page: 58 ident: CR208 article-title: Pharmacological and neuromodulatory treatments for panic disorder: clinical trials from 2010 to 2018 publication-title: Psychiatry Investig doi: 10.30773/pi.2018.12.21.1 – volume: 13 start-page: 321 year: 2016 end-page: 328 ident: CR202 article-title: Selective 5-HT7 receptor activation may enhance synaptic plasticity through N-methyl-D-aspartate (NMDA) receptor activity in the visual cortex publication-title: Curr Neurovasc Res doi: 10.2174/1567202613666160823164136 – volume: 45 start-page: 233 year: 2014 end-page: 245 ident: CR168 article-title: Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2014.06.005 – volume: 66 start-page: 353 year: 2005 end-page: 359 ident: CR103 article-title: Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder publication-title: J Clin Psychiatry doi: 10.4088/jcp.v66n0312 – volume: 10 start-page: 27 issue: 1 year: 2005 end-page: 39 ident: CR182 article-title: Phenotype of schizophrenia: a review and formulation publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001563 – volume: 60 start-page: 214 issue: 1 year: 2009 end-page: 225 ident: CR80 article-title: Descending control of nociception: specificity, recruitment and plasticity publication-title: Brain Res Rev doi: 10.1016/j.brainresrev.2008.12.009 – volume: 277 start-page: 146 year: 2015 end-page: 192 ident: CR132 article-title: The role of serotonin in drug use and addiction publication-title: Behav Brain Res doi: 10.1016/j.bbr.2014.04.007 – volume: 57 start-page: 1510 year: 2005 end-page: 1516 ident: CR65 article-title: Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C] DASB publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.02.028 – volume: 36 start-page: 79 issue: 1 year: 2010 ident: CR41 article-title: The neurobiological basis of ADHD publication-title: Ital J Pediatr doi: 10.1186/1824-7288-36-79 – volume: 45 start-page: 161 year: 2017 end-page: 166 ident: CR4 article-title: Maternal SSRI exposure increases the risk of autistic offspring: a meta-analysis and systematic review publication-title: Eur Psychiatry doi: 10.1016/j.eurpsy.2017.06.001 – volume: 27 start-page: 703 year: 2013 end-page: 716 ident: CR31 article-title: Serotonin 5-HT 1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research publication-title: CNS Drugs doi: 10.1007/s40263-013-0071-0 – volume: 61 start-page: 761 year: 2009 end-page: 777 ident: CR62 article-title: Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system publication-title: Pharmacol Rep doi: 10.1016/s1734-1140(09)70132-x – year: 2013 ident: CR201 article-title: Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD) publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858 – volume: 32 start-page: 15148 year: 2012 end-page: 15157 ident: CR67 article-title: Presynaptic α4β2 nicotinic acetylcholine receptors increase glutamate release and serotonin neuron excitability in the dorsal raphe nucleus publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0941-12.2012 – volume: 357 start-page: 98 year: 2019 end-page: 103 ident: CR6 article-title: Effects of 5-HT5A receptor blockade on amnesia or forgetting publication-title: Behav Brain Res doi: 10.1016/j.bbr.2018.01.009 – volume: 172 start-page: 525 year: 2018 end-page: 533 ident: CR117 article-title: Associations between brain structure and connectivity in infants and exposure to selective serotonin reuptake inhibitors during pregnancy publication-title: JAMA Pediatr doi: 10.1001/jamapediatrics.2017.5227 – volume: 500 start-page: 233 year: 2020 end-page: 240 ident: CR149 article-title: Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: Diagnosis utility publication-title: Clin Chim Acta doi: 10.1016/j.cca.2019.10.023 – year: 2015 ident: CR119 article-title: Familial risk for major depression is associated with lower striatal 5-HT4 receptor binding publication-title: Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyu034 – volume: 46 start-page: 1124 year: 2016 end-page: 1130 ident: CR123 article-title: Brief report: whole blood serotonin levels and gastrointestinal symptoms in autism spectrum disorder publication-title: J Autism Dev Disord doi: 10.1007/s10803-015-2646-8 – volume: 50 start-page: 593 issue: 8 year: 2008 end-page: 597 ident: CR120 article-title: Serotonin and dopamine transporter binding in children with autism determined by SPECT publication-title: Dev Med Child Neurol doi: 10.1111/j.1469-8749.2008.03027.x – volume: 67 start-page: 59 issue: 1 year: 2010 end-page: 68 ident: CR135 article-title: Brain serotonin and dopamine transporter bindings in adults with high-functioning autism publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2009.137 – volume: 169 start-page: 292 issue: 3 year: 2012 end-page: 299 ident: CR82 article-title: A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2011.10050764 – volume: 2019 start-page: 1389296 year: 2019 ident: CR184 article-title: The Role of Descending Pain Modulation in Chronic Primary Pain: Potential Application of Drugs Targeting Serotonergic System publication-title: Neural Plast doi: 10.1155/2019/1389296 – volume: 47 start-page: S26 year: 2007 end-page: S43 ident: CR77 article-title: New migraine and pain research publication-title: Headache doi: 10.1111/j.1526-4610.2006.00675.x – volume: 7 start-page: E421 issue: 2 year: 2008 end-page: E433 ident: CR200 article-title: Serotonin transporters: implications for antidepressant drug development publication-title: AAPS J doi: 10.1208/aapsj070242 – volume: 135 start-page: 2358 year: 2012 end-page: 2374 ident: CR12 article-title: Fluoxetine restores spatial learning but not accelerated forgetting in mesial temporal lobe epilepsy publication-title: Brain doi: 10.1093/brain/aws176 – volume: 297 start-page: 41 year: 2016 end-page: 50 ident: CR73 article-title: A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: modulation of serotonergic system publication-title: Behav Brain Res doi: 10.1016/j.bbr.2015.10.007 – volume: 62 start-page: 669 issue: 6 year: 2007 end-page: 679 ident: CR190 article-title: 3, 4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice publication-title: Biol Psychiat doi: 10.1016/j.biopsych.2006.11.005 – ident: CR205 – ident: CR131 – volume: 29 start-page: 459 year: 2015 end-page: 525 ident: CR34 article-title: Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines publication-title: Psychopharmacol doi: 10.1177/0269881115581093 – volume: 10 start-page: 346 issue: 3 year: 2015 end-page: 358 ident: CR32 article-title: Disruption of transient serotonin accumulation by non-serotonin-producing neurons impairs cortical map development publication-title: Cell rep doi: 10.1016/j.celrep.2014.12.033 – volume: 107 start-page: 206 issue: 2–3 year: 2009 end-page: 212 ident: CR3 article-title: Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial publication-title: Schizophrenia research Schizophr Res doi: 10.1016/j.schres.2008.08.004 – volume: 10 start-page: 1118 year: 2009 end-page: 1138 ident: CR160 article-title: The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression publication-title: Curr Drug Targets doi: 10.2174/138945009789735192 – volume: 3 start-page: 425 year: 2016 end-page: 435 ident: CR173 article-title: Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(16)00012-2 – volume: 213 start-page: 265 year: 2011 end-page: 287 ident: CR30 article-title: The role of serotonin receptor subtypes in treating depression: a review of animal studies publication-title: Psychopharmacology doi: 10.1007/s00213-010-2097-z – volume: 197 start-page: 8 year: 2011 end-page: 16 ident: CR33 article-title: Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.09.036 – volume: 25 start-page: 6460 year: 2005 end-page: 6466 ident: CR91 article-title: A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5261-04.2005 – volume: 10 start-page: 450 year: 2015 end-page: 465 ident: CR49 article-title: Autism: oxytocin, serotonin, and social reward publication-title: Soc Neurosci doi: 10.1080/17470919.2015.1087875 – volume: 91 start-page: 652 year: 2007 end-page: 657 ident: CR86 article-title: Brain serotonin depletion impairs short-term memory, but not long-term memory in rats publication-title: Physiol Behav doi: 10.1016/j.physbeh.2007.03.028 – volume: 194 start-page: 73 issue: 1 year: 2007 end-page: 81 ident: CR97 article-title: Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain publication-title: Psychopharmacology doi: 10.1007/s00213-007-0826-8 – volume: 1630 start-page: 10 year: 2016 end-page: 17 ident: CR148 article-title: Circadian rhythms of clock gene expression in the cerebellum of serotonin-deficient Pet-1 knockout mice publication-title: Brain Res doi: 10.1016/j.brainres.2015.10.044 – volume: 13 start-page: 103 issue: 1 year: 2018 end-page: 110 ident: CR161 article-title: Pimavanserin: novel pharmacotherapy for Parkinson’s disease psychosis publication-title: Expert Opin Drug Discov doi: 10.1080/17460441.2018.1394838 – volume: 151 start-page: 320 year: 2008 end-page: 328 ident: CR166 article-title: Δ9-Tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.10.026 – volume: 33 start-page: 1402 year: 2008 end-page: 1412 ident: CR63 article-title: The 5-HT 2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301509 – volume: 45 start-page: 54 year: 2013 end-page: 63 ident: CR75 article-title: Monoamine neurocircuitry in depression and strategies for new treatments publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2013.04.009 – volume: 38 start-page: 538 year: 2018 end-page: 551 ident: CR85 article-title: Association of serotonin receptors with attention deficit hyperactivity disorder: a systematic review and meta-analysis publication-title: Curr Med Sci doi: 10.1007/s11596-018-1912-3 – volume: 11 start-page: 515 year: 2018 ident: CR138 article-title: Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential publication-title: J Pain Res doi: 10.2147/JPR.S132833 – volume: 25 start-page: 115 issue: 2 year: 2004 end-page: 122 ident: CR59 article-title: Massage therapy effects on depressed pregnant women publication-title: J Psychosom Obstet Gynaecol doi: 10.1080/01674820412331282231 – volume: 42 start-page: 349 issue: 5 year: 2019 end-page: 360 ident: CR69 article-title: Periaqueductal gray sheds light on dark areas of psychopathology publication-title: Trends Neurosci doi: 10.1016/j.tins.2019.03.004 – ident: CR175 – volume: 49 start-page: 121 issue: 1 year: 2010 end-page: 126 ident: CR125 article-title: Reduced serotonin transporter binding in the insular cortex in patients with obsessive–compulsive disorder: A [11C] DASB PET study publication-title: Neuroimage doi: 10.1016/j.neuroimage.2009.07.069 – volume: 16 start-page: 210 issue: 2 year: 2018 end-page: 221 ident: CR38 article-title: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 receptors and their role in the modulation of pain response in the central nervous system publication-title: Curr Neuropharmacol doi: 10.2174/1570159X15666170911121027 – volume: 5 start-page: 553 year: 1814 end-page: 561 ident: CR58 article-title: (2011) The neurotransmitter serotonin interrupts α-synuclein amyloid maturation publication-title: Biochimica et Biophysica Acta BBA-Proteins and Proteomics doi: 10.1016/j.bbapap.2011.02.008 – volume: 66 start-page: 583 issue: 6 year: 2009 end-page: 590 ident: CR99 article-title: Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2009.30 – volume: 10 start-page: 53 year: 2019 ident: CR108 article-title: Lpm580098, a novel triple reuptake inhibitor of serotonin, noradrenaline, and dopamine, attenuates neuropathic pain publication-title: Front Pharmacol doi: 10.3389/fphar.2019.00053 – volume: 235 start-page: 836 issue: 2 year: 2020 end-page: 847 ident: CR23 article-title: Optogenetic stimulation of serotonin nuclei retrieve the lost memory in Alzheimer's disease publication-title: J Cell Physiol doi: 10.1002/jcp.29077 – volume: 34 start-page: 12379 issue: 37 year: 2014 end-page: 12393 ident: CR156 article-title: Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1020-13.2014 – volume: 109 start-page: 1166 issue: 6 year: 2020 end-page: 1174 ident: CR152 article-title: Pain-related increase in serotonin transporter gene methylation associates with emotional regulation in 4.5-year-old preterm-born children publication-title: Acta Paediatr doi: 10.1111/apa.15077 – volume: 18 start-page: 439 issue: 5–6 year: 2007 end-page: 446 ident: CR198 article-title: Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e3282d28f9c – volume: 37 start-page: 631 year: 2007 end-page: 635 ident: CR151 article-title: Involvement of brain serotonin 5-HT 1A receptors in genetic predisposition to aggressive behavior publication-title: Neurosci Behav Physiol doi: 10.1007/s11055-007-0062-z – volume: 12 start-page: 982 year: 2018 ident: CR154 article-title: Somato-dendritic regulation of raphe serotonin neurons; a key to antidepressant action publication-title: Front Neurosci doi: 10.3389/fnins.2018.00982 – volume: 80 start-page: 791 year: 2013 end-page: 794 ident: CR53 article-title: A serotonin hypothesis of schizophrenia publication-title: Med Hypotheses doi: 10.1016/j.mehy.2013.03.013 – volume: 62 start-page: 1005 year: 2010 end-page: 1014 ident: CR61 article-title: Effects of serotonin (5-HT) 6 receptor ligands on responding for cocaine reward and seeking in rats publication-title: Pharmacol Rep doi: 10.1016/s1734-1140(10)70362-5 – volume: 63 start-page: 309 issue: 3 year: 2008 end-page: 316 ident: CR21 article-title: Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2007.06.024 – volume: 39 start-page: 1366 year: 2014 end-page: 1378 ident: CR128 article-title: Rapid anxiolytic effects of a 5-HT 4 receptor agonist are mediated by a neurogenesis-independent mechanism publication-title: Neuropsychopharmacology doi: 10.1038/npp.2013.332 – volume: 8 start-page: 1 year: 2018 end-page: 10 ident: CR113 article-title: Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline publication-title: Transl Psychiatry doi: 10.1038/s41398-018-0128-4 – volume: 252 start-page: 246 year: 2013 end-page: 251 ident: CR70 article-title: Role of 5-HT5A receptors in the consolidation of memory publication-title: Behav Brain Res doi: 10.1016/j.bbr.2013.05.051 – volume: 36 start-page: 1275 issue: 6 year: 2011 end-page: 1288 ident: CR130 article-title: Pharmacological blockade of 5-HT 7 receptors as a putative fast acting antidepressant strategy publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.13 – volume: 7 start-page: 1357 issue: 10 year: 2007 end-page: 1374 ident: CR140 article-title: Role of the serotonin system in ADHD: treatment implications publication-title: Expert Rev Neurother doi: 10.1586/14737175.7.10.1357 – volume: 79 start-page: 345 year: 2014 end-page: 358 ident: CR169 article-title: Visceral analgesic effect of 5-HT4 receptor agonist in rats involves the rostroventral medulla (RVM) publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.12.006 – volume: 38 start-page: 252 issue: 2 year: 2012 end-page: 259 ident: CR185 article-title: Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2012.04.008 – volume: 36 start-page: 396 year: 2014 end-page: 408 ident: CR101 article-title: Increased aggression, improved spatial memory, and reduced anxiety-like behaviour in adult male mice exposed to fluoxetine early in life publication-title: Dev Neurosci doi: 10.1159/000363102 – volume: 20 start-page: 1843 year: 2006 end-page: 1854 ident: CR106 article-title: Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells publication-title: FASEB J doi: 10.1096/fj.06-5724com – volume: 595 start-page: 4141 issue: 13 year: 2017 end-page: 4150 ident: CR109 article-title: Does exercise increase or decrease pain? Central mechanisms underlying these two phenomena publication-title: J Physiol doi: 10.1113/JP273355 – volume: 4 start-page: 1 issue: 1 year: 2019 end-page: 22 ident: CR114 article-title: History and progress of hypotheses and clinical trials for Alzheimer’s disease publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-019-0063-8 – volume: 322 start-page: 1561 issue: 16 year: 2019 end-page: 1569 ident: CR157 article-title: Effect of fluoxetine on obsessive-compulsive behaviors in children and adolescents with autism spectrum disorders: a randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2019.14685 – volume: 23 start-page: 1047 issue: 12 year: 2009 end-page: 1055 ident: CR146 article-title: Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder publication-title: CNS Drugs doi: 10.2165/11530240-000000000-00000 – volume: 8 start-page: 453 year: 2015 ident: CR172 article-title: Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activity publication-title: Front Behav Neurosci doi: 10.3389/fnbeh.2014.00453 – volume: 166 start-page: 1290 issue: 4 year: 2012 end-page: 1302 ident: CR102 article-title: Distribution of 5-ht1E receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.2012.01868.x – volume: 9 start-page: S76 year: 2020 ident: CR137 article-title: Obsessive-compulsive disorder in children and adolescents: epidemiology, diagnosis and management publication-title: Transl Pediatr doi: 10.21037/tp.2019.10.02 – ident: 1064_CR27 doi: 10.1016/B978-0-12-800901-7.00009-4 – volume: 589 start-page: 1728 year: 2015 ident: 1064_CR54 publication-title: FEBS Lett doi: 10.1016/j.febslet.2015.05.054 – volume: 8 start-page: e46464 year: 2019 ident: 1064_CR89 publication-title: Elife doi: 10.7554/eLife.46464 – volume: 20 start-page: 223 year: 2018 ident: 1064_CR134 publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2018.20.3/dnaber – volume: 80 start-page: 791 year: 2013 ident: 1064_CR53 publication-title: Med Hypotheses doi: 10.1016/j.mehy.2013.03.013 – volume: 10 start-page: 89 year: 2018 ident: 1064_CR18 publication-title: ACS Chem Neurosci doi: 10.1021/acschemneuro.8b00283 – volume: 46 start-page: 1124 year: 2016 ident: 1064_CR123 publication-title: J Autism Dev Disord doi: 10.1007/s10803-015-2646-8 – volume: 65 start-page: 40 year: 2010 ident: 1064_CR159 publication-title: Neuron doi: 10.1016/j.neuron.2009.12.003 – volume: 4 start-page: 409 year: 2017 ident: 1064_CR78 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(17)30015-9 – volume: 74 start-page: 1011 year: 2017 ident: 1064_CR115 publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2017.2432 – volume: 45 start-page: 161 year: 2017 ident: 1064_CR4 publication-title: Eur Psychiatry doi: 10.1016/j.eurpsy.2017.06.001 – volume: 172 start-page: 2532 issue: 10 year: 2015 ident: 1064_CR192 publication-title: Br J Pharmacol doi: 10.1111/bph.13071 – volume: 33 start-page: 424 year: 2010 ident: 1064_CR44 publication-title: Trends Neurosci doi: 10.1016/j.tins.2010.05.005 – volume: 12 start-page: 731 year: 2018 ident: 1064_CR162 publication-title: J Cell Commun Signal doi: 10.1007/s12079-018-0482-2 – volume: 33 start-page: 3 issue: 1 year: 2019 ident: 1064_CR203 publication-title: Psychopharmacol doi: 10.1177/0269881118817384 – volume: 43 start-page: 1623 issue: 7 year: 2018 ident: 1064_CR15 publication-title: Neuropsychopharmacology doi: 10.1038/s41386-018-0013-0 – volume: 505 start-page: 10 year: 2011 ident: 1064_CR126 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2011.07.036 – volume: 36 start-page: 396 year: 2014 ident: 1064_CR101 publication-title: Dev Neurosci doi: 10.1159/000363102 – volume: 83 start-page: 663 issue: 3 year: 2014 ident: 1064_CR50 publication-title: Neuron doi: 10.1016/j.neuron.2014.07.002 – volume: 109 start-page: 1166 issue: 6 year: 2020 ident: 1064_CR152 publication-title: Acta Paediatr doi: 10.1111/apa.15077 – volume: 74 start-page: 858 issue: 5 year: 2012 ident: 1064_CR197 publication-title: Neuron doi: 10.1016/j.neuron.2012.03.017 – volume: 62 start-page: 1005 year: 2010 ident: 1064_CR61 publication-title: Pharmacol Rep doi: 10.1016/s1734-1140(10)70362-5 – volume: 23 start-page: 1990 issue: 10 year: 2018 ident: 1064_CR66 publication-title: Mol Psychiatry doi: 10.1038/mp.2017.165 – volume: 1630 start-page: 10 year: 2016 ident: 1064_CR148 publication-title: Brain Res doi: 10.1016/j.brainres.2015.10.044 – volume: 10 start-page: 346 issue: 3 year: 2015 ident: 1064_CR32 publication-title: Cell rep doi: 10.1016/j.celrep.2014.12.033 – volume: 79 start-page: 345 year: 2014 ident: 1064_CR169 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.12.006 – volume: 61 start-page: 1081 year: 2007 ident: 1064_CR105 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.05.022 – volume: 4 start-page: 1 issue: 1 year: 2019 ident: 1064_CR114 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-019-0063-8 – volume: 134 start-page: 104 year: 2015 ident: 1064_CR144 publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2015.09.005 – year: 2015 ident: 1064_CR76 publication-title: Sci Rep doi: 10.1038/srep12667 – volume: 19 start-page: 93 year: 2017 ident: 1064_CR11 publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2017.19.2/bbandelow – volume: 105 start-page: 351 year: 2016 ident: 1064_CR139 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2016.01.035 – volume: 357 start-page: 98 year: 2019 ident: 1064_CR6 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2018.01.009 – volume: 173 start-page: 1438 year: 2016 ident: 1064_CR5 publication-title: Pharmacol doi: 10.1111/bph.13432 – volume: 70 start-page: 127 year: 2016 ident: 1064_CR8 publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2015.12.004 – volume: 169 start-page: 292 issue: 3 year: 2012 ident: 1064_CR82 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2011.10050764 – volume: 41 start-page: 641 year: 2010 ident: 1064_CR45 publication-title: Child Psychiatry Hum Dev doi: 10.1007/s10578-010-0193-2 – volume: 247 start-page: 253 year: 2013 ident: 1064_CR24 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2013.05.050 – volume: 10 start-page: 450 year: 2015 ident: 1064_CR49 publication-title: Soc Neurosci doi: 10.1080/17470919.2015.1087875 – volume: 49 start-page: 121 issue: 1 year: 2010 ident: 1064_CR125 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2009.07.069 – volume: 60 start-page: 214 issue: 1 year: 2009 ident: 1064_CR80 publication-title: Brain Res Rev doi: 10.1016/j.brainresrev.2008.12.009 – volume: 59 start-page: 1116 year: 2006 ident: 1064_CR52 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.02.013 – volume: 36 start-page: 1275 issue: 6 year: 2011 ident: 1064_CR130 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.13 – volume: 37 start-page: 631 year: 2007 ident: 1064_CR151 publication-title: Neurosci Behav Physiol doi: 10.1007/s11055-007-0062-z – volume: 12 start-page: 982 year: 2018 ident: 1064_CR154 publication-title: Front Neurosci doi: 10.3389/fnins.2018.00982 – ident: 1064_CR175 – volume: 4 start-page: e06346 year: 2015 ident: 1064_CR35 publication-title: Elife doi: 10.7554/eLife.06346 – volume: 14 start-page: 280 issue: 3 year: 2009 ident: 1064_CR158 publication-title: Mol Psychiatry doi: 10.1038/mp.2008.89 – volume: 14 start-page: 805 issue: 12 year: 2004 ident: 1064_CR111 publication-title: Pharmacogenetics doi: 10.1097/00008571-200412000-00003 – volume: 8 start-page: 1 year: 2018 ident: 1064_CR113 publication-title: Transl Psychiatry doi: 10.1038/s41398-018-0128-4 – volume: 62 start-page: 870 year: 2007 ident: 1064_CR28 publication-title: Psychiatry doi: 10.1016/j.biopsych.2007.03.016 – volume: 13 start-page: 321 year: 2016 ident: 1064_CR202 publication-title: Curr Neurovasc Res doi: 10.2174/1567202613666160823164136 – volume: 13 start-page: 103 issue: 1 year: 2018 ident: 1064_CR161 publication-title: Expert Opin Drug Discov doi: 10.1080/17460441.2018.1394838 – volume: 66 start-page: 583 issue: 6 year: 2009 ident: 1064_CR99 publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2009.30 – volume: 525 start-page: 116 year: 2017 ident: 1064_CR112 publication-title: J Comp Neurol doi: 10.1002/cne.24044 – volume: 18 start-page: 1606 year: 2015 ident: 1064_CR165 publication-title: Nat Neurosci doi: 10.1038/nn.4116 – volume: 165 start-page: 107931 year: 2020 ident: 1064_CR164 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2019.107931 – volume: 39 start-page: 1366 year: 2014 ident: 1064_CR128 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2013.332 – volume: 75 start-page: 223 year: 2013 ident: 1064_CR22 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.07.003 – volume: 83 start-page: 197 issue: 4 year: 2014 ident: 1064_CR57 publication-title: Psychother Psychosom doi: 10.1159/000362803 – volume: 172 start-page: 525 year: 2018 ident: 1064_CR117 publication-title: JAMA Pediatr doi: 10.1001/jamapediatrics.2017.5227 – volume: 139 start-page: 705 year: 2003 ident: 1064_CR187 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0705290 – volume: 60 start-page: 576 issue: 3 year: 2020 ident: 1064_CR104 publication-title: Headache doi: 10.1111/head.13731 – volume: 24 start-page: 191 year: 2012 ident: 1064_CR16 publication-title: J Neuropsychiatry Clin Neurosci doi: 10.1176/appi.neuropsych.11080202 – volume: 7 start-page: 71 year: 2013 ident: 1064_CR29 publication-title: Front Integr Neurosci doi: 10.3389/fnint.2013.00071 – volume: 7 start-page: 1357 issue: 10 year: 2007 ident: 1064_CR140 publication-title: Expert Rev Neurother doi: 10.1586/14737175.7.10.1357 – volume: 235 start-page: 1317 issue: 5 year: 2018 ident: 1064_CR188 publication-title: Psychopharmacology doi: 10.1007/s00213-018-4872-1 – volume: 166 start-page: 1290 issue: 4 year: 2012 ident: 1064_CR102 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.2012.01868.x – volume: 32 start-page: 15148 year: 2012 ident: 1064_CR67 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0941-12.2012 – volume: 167 start-page: 107703 year: 2020 ident: 1064_CR143 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2019.107703 – volume: 62 start-page: 1111 year: 2007 ident: 1064_CR25 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.11.023 – volume: 10 start-page: 27 issue: 1 year: 2005 ident: 1064_CR182 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001563 – volume: 15 start-page: e0227554 issue: 1 year: 2020 ident: 1064_CR79 publication-title: PLoS ONE doi: 10.1371/journal.pone.0227554 – volume: 67 start-page: 155 year: 2013 ident: 1064_CR176 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.10.026 – volume: 42 start-page: 349 issue: 5 year: 2019 ident: 1064_CR69 publication-title: Trends Neurosci doi: 10.1016/j.tins.2019.03.004 – volume: 29 start-page: 414 year: 2014 ident: 1064_CR88 publication-title: Eur Psychiatry doi: 10.1016/j.eurpsy.2013.11.004 – volume: 45 start-page: 54 year: 2013 ident: 1064_CR75 publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2013.04.009 – volume: 252 start-page: 246 year: 2013 ident: 1064_CR70 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2013.05.051 – volume: 155 start-page: 528 year: 2018 ident: 1064_CR150 publication-title: Neurobiol Learn Mem doi: 10.1016/j.nlm.2018.05.007 – volume: 36 start-page: 79 issue: 1 year: 2010 ident: 1064_CR41 publication-title: Ital J Pediatr doi: 10.1186/1824-7288-36-79 – volume: 289 start-page: 8252 year: 2014 ident: 1064_CR194 publication-title: J Biol Chem doi: 10.1074/jbc.M113.522094 – volume: 2019 start-page: 1389296 year: 2019 ident: 1064_CR184 publication-title: Neural Plast doi: 10.1155/2019/1389296 – volume: 63 start-page: 1150 year: 2012 ident: 1064_CR56 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.06.061 – volume: 25 start-page: 115 issue: 2 year: 2004 ident: 1064_CR59 publication-title: J Psychosom Obstet Gynaecol doi: 10.1080/01674820412331282231 – year: 2019 ident: 1064_CR81 publication-title: J Autism Dev Disord doi: 10.1007/s10803-019-04120-y – volume: 61 start-page: 671 issue: 5 year: 2007 ident: 1064_CR51 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.05.015 – volume: 33 start-page: 10011 year: 2013 ident: 1064_CR42 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4733-12.2013 – volume: 7 start-page: 76 year: 2013 ident: 1064_CR55 publication-title: Front Cell Neurosci doi: 10.3389/fncel.2013.00076 – volume: 210 start-page: 106 year: 2018 ident: 1064_CR207 publication-title: Life Sci. doi: 10.1016/j.lfs.2018.08.050 – volume: 22 start-page: 452 year: 2015 ident: 1064_CR118 publication-title: Learn Mem doi: 10.1101/lm.037317.114 – volume: 27 start-page: 6045 issue: 22 year: 2007 ident: 1064_CR206 publication-title: Journal of J Neurosci doi: 10.1523/JNEUROSCI.1623-07.2007 – volume: 11 start-page: 139 year: 2017 ident: 1064_CR186 publication-title: Front Cell Neurosci doi: 10.3389/fncel.2017.00139 – volume: 15 start-page: 410 year: 2014 ident: 1064_CR147 publication-title: Nat Rev Neurosci doi: 10.1038/nrn3746 – volume: 20 start-page: 1843 year: 2006 ident: 1064_CR106 publication-title: FASEB J doi: 10.1096/fj.06-5724com – volume: 190 start-page: 189 year: 2008 ident: 1064_CR121 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2008.02.027 – volume: 136 start-page: 135 year: 2014 ident: 1064_CR26 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2014.01.002 – volume: 23 start-page: 2087 year: 2018 ident: 1064_CR178 publication-title: Molecules doi: 10.3390/molecules23082087 – volume: 12 start-page: 196 year: 2014 ident: 1064_CR110 publication-title: Clin Psychopharmacol Neurosci doi: 10.9758/cpn.2014.12.3.196 – volume: 123 start-page: 382 issue: 2 year: 2009 ident: 1064_CR47 publication-title: Behav Neurosci doi: 10.1037/a0014592 – volume: 151 start-page: 93 year: 2004 ident: 1064_CR174 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2003.08.015 – year: 2015 ident: 1064_CR119 publication-title: Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyu034 – volume: 12 start-page: 667 issue: 9 year: 2013 ident: 1064_CR71 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd4075 – volume: 193 start-page: 229 year: 2008 ident: 1064_CR136 publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.107.041186 – volume: 64 start-page: 63 year: 2016 ident: 1064_CR9 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2016.02.008 – volume: 4 start-page: 1744 year: 2008 ident: 1064_CR94 publication-title: Mol Pain doi: 10.1186/1744-8069-4-54 – volume: 18 start-page: 97 year: 2018 ident: 1064_CR46 publication-title: Neuroimage Clin doi: 10.1016/j.nicl.2018.01.016 – volume: 21 start-page: 1239 issue: 12 year: 2009 ident: 1064_CR98 publication-title: Neurogastroenterol Motil doi: 10.1111/j.1365-2982.2009.01370.x – volume: 8 start-page: 453 year: 2015 ident: 1064_CR172 publication-title: Front Behav Neurosci doi: 10.3389/fnbeh.2014.00453 – volume: 27 start-page: 575 year: 2013 ident: 1064_CR39 publication-title: J Psychopharmacol doi: 10.1177/0269881113482531 – ident: 1064_CR131 doi: 10.1007/978-3-7091-6301-6_24 – volume: 16 start-page: 50 issue: 1 year: 2019 ident: 1064_CR208 publication-title: Psychiatry Investig doi: 10.30773/pi.2018.12.21.1 – volume: 281 start-page: 28901 year: 2006 ident: 1064_CR133 publication-title: J Biol Chem doi: 10.1074/jbc.M602848200 – volume: 9 start-page: S76 year: 2020 ident: 1064_CR137 publication-title: Transl Pediatr doi: 10.21037/tp.2019.10.02 – volume: 24 start-page: 19 year: 2016 ident: 1064_CR60 publication-title: Complement Ther Clin Pract doi: 10.1016/j.ctcp.2016.04.005 – start-page: 915 volume-title: Serotonin and synaptic transmission in the cerebellum year: 2012 ident: 1064_CR163 – volume: 197 start-page: 8 year: 2011 ident: 1064_CR33 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.09.036 – year: 2013 ident: 1064_CR201 publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858 – volume: 8 start-page: 1 issue: 1 year: 2018 ident: 1064_CR196 publication-title: Sci Rep doi: 10.1038/s41598-018-28702-5 – volume: 11 start-page: 672 year: 2014 ident: 1064_CR195 publication-title: Curr Alzheimer Res doi: 10.2174/1567205011666140812114715 – volume: 26 start-page: 766 year: 2015 ident: 1064_CR83 publication-title: Behav Pharmacol doi: 10.1097/FBP.0000000000000132 – volume: 16 start-page: 210 issue: 2 year: 2018 ident: 1064_CR38 publication-title: Curr Neuropharmacol doi: 10.2174/1570159X15666170911121027 – volume: 537 start-page: 97 year: 2016 ident: 1064_CR122 publication-title: Nature doi: 10.1038/nature19318 – volume: 183 start-page: 113 issue: 2 year: 2020 ident: 1064_CR87 publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.32766 – volume: 59 start-page: 399 year: 2008 ident: 1064_CR107 publication-title: Neuron doi: 10.1016/j.neuron.2008.06.023 – volume: 369 start-page: 2406 issue: 25 year: 2013 ident: 1064_CR90 publication-title: N Engl J Med doi: 10.1056/NEJMoa1301449 – volume: 367 start-page: 2444 year: 2012 ident: 1064_CR93 publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2012.0109 – volume: 235 start-page: 836 issue: 2 year: 2020 ident: 1064_CR23 publication-title: J Cell Physiol doi: 10.1002/jcp.29077 – volume: 71 start-page: 176 year: 2016 ident: 1064_CR155 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2016.08.031 – volume: 500 start-page: 233 year: 2020 ident: 1064_CR149 publication-title: Clin Chim Acta doi: 10.1016/j.cca.2019.10.023 – volume: 18 start-page: 439 issue: 5–6 year: 2007 ident: 1064_CR198 publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e3282d28f9c – volume: 141 start-page: 92 year: 2004 ident: 1064_CR124 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0705576 – volume: 110 start-page: 60 year: 2020 ident: 1064_CR181 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2019.04.012 – volume: 241 start-page: 40 issue: 1 year: 2016 ident: 1064_CR189 publication-title: A preliminary study Exp Biol Med doi: 10.1177/1535370215596383 – volume: 91 start-page: 652 year: 2007 ident: 1064_CR86 publication-title: Physiol Behav doi: 10.1016/j.physbeh.2007.03.028 – volume: 151 start-page: 320 year: 2008 ident: 1064_CR166 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.10.026 – volume: 45 start-page: 233 year: 2014 ident: 1064_CR168 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2014.06.005 – volume: 29 start-page: 260 year: 2018 ident: 1064_CR116 publication-title: J Addict Nurs doi: 10.1097/JAN.0000000000000250 – volume: 13 start-page: 933 year: 2010 ident: 1064_CR204 publication-title: Neuropsychopharmacol doi: 10.1017/S146114571000012X – volume: 67 start-page: 59 issue: 1 year: 2010 ident: 1064_CR135 publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2009.137 – volume: 124 start-page: 44 year: 2020 ident: 1064_CR10 publication-title: Br J Anaesth doi: 10.1016/j.bja.2019.08.010 – volume: 38 start-page: 538 year: 2018 ident: 1064_CR85 publication-title: Curr Med Sci doi: 10.1007/s11596-018-1912-3 – volume: 322 start-page: 1561 issue: 16 year: 2019 ident: 1064_CR157 publication-title: JAMA doi: 10.1001/jama.2019.14685 – volume: 8 start-page: 206 year: 2007 ident: 1064_CR43 publication-title: Nat Rev Neurosci doi: 10.1038/nrn2075 – volume: 33 start-page: 1402 year: 2008 ident: 1064_CR63 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301509 – volume: 26 start-page: 883 issue: 10 year: 2012 ident: 1064_CR7 publication-title: CNS Drugs doi: 10.2165/11635850-000000000-00000 – volume: 44 start-page: 449 year: 2011 ident: 1064_CR153 publication-title: Mol Neurobiol doi: 10.1007/s12035-011-8214-0 – volume: 297 start-page: 41 year: 2016 ident: 1064_CR73 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2015.10.007 – volume: 9 start-page: 1 year: 2018 ident: 1064_CR92 publication-title: Nat Commun doi: 10.1038/s41467-018-04840-2 – volume: 3 start-page: 425 year: 2016 ident: 1064_CR173 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(16)00012-2 – volume: 6 start-page: 162 year: 2015 ident: 1064_CR179 publication-title: Front Pharmacol doi: 10.3389/fphar.2015.00162 – volume: 110 start-page: 42 year: 2013 ident: 1064_CR199 publication-title: Physiol Behav doi: 10.1016/j.physbeh.2012.12.009 – volume: 11 start-page: 515 year: 2018 ident: 1064_CR138 publication-title: J Pain Res doi: 10.2147/JPR.S132833 – volume: 61 start-page: 761 year: 2009 ident: 1064_CR62 publication-title: Pharmacol Rep doi: 10.1016/s1734-1140(09)70132-x – volume: 63 start-page: 12 year: 2014 ident: 1064_CR13 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2013.11.010 – volume: 66 start-page: 353 year: 2005 ident: 1064_CR103 publication-title: J Clin Psychiatry doi: 10.4088/jcp.v66n0312 – volume: 29 start-page: 459 year: 2015 ident: 1064_CR34 publication-title: Psychopharmacol doi: 10.1177/0269881115581093 – volume: 26 start-page: 488 issue: 5 year: 2018 ident: 1064_CR36 publication-title: Exp Clin Psychopharmacol doi: 10.1037/pha0000209 – volume: 12 start-page: 304 year: 2002 ident: 1064_CR180 publication-title: Hippocampus doi: 10.1002/hipo.10012 – volume: 10 start-page: 53 year: 2019 ident: 1064_CR108 publication-title: Front Pharmacol doi: 10.3389/fphar.2019.00053 – volume: 135 start-page: 63 year: 2018 ident: 1064_CR193 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2018.03.005 – volume: 50 start-page: 593 issue: 8 year: 2008 ident: 1064_CR120 publication-title: Dev Med Child Neurol doi: 10.1111/j.1469-8749.2008.03027.x – volume: 62 start-page: 669 issue: 6 year: 2007 ident: 1064_CR190 publication-title: Biol Psychiat doi: 10.1016/j.biopsych.2006.11.005 – volume: 17 start-page: 1777 year: 2014 ident: 1064_CR142 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145714000637 – volume: 63 start-page: 309 issue: 3 year: 2008 ident: 1064_CR21 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2007.06.024 – volume: 368 start-page: 20120536 issue: 1615 year: 2013 ident: 1064_CR20 publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2012.0536 – volume: 65 start-page: 813 year: 2013 ident: 1064_CR129 publication-title: Pharmacol Rep doi: 10.1016/s1734-1140(13)71062-4 – volume: 16 start-page: 557 issue: 3 year: 2013 ident: 1064_CR48 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145712000740 – volume: 23 start-page: 1047 issue: 12 year: 2009 ident: 1064_CR146 publication-title: CNS Drugs doi: 10.2165/11530240-000000000-00000 – volume: 57 start-page: 1510 year: 2005 ident: 1064_CR65 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.02.028 – volume: 28 start-page: 629 year: 2007 ident: 1064_CR171 publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2007.10.009 – volume: 10 start-page: 1118 year: 2009 ident: 1064_CR160 publication-title: Curr Drug Targets doi: 10.2174/138945009789735192 – volume: 16 start-page: 235 year: 2013 ident: 1064_CR17 publication-title: Neuropsychopharmacol doi: 10.1017/S1461145712000119 – volume: 47 start-page: S26 year: 2007 ident: 1064_CR77 publication-title: Headache doi: 10.1111/j.1526-4610.2006.00675.x – volume: 34 start-page: 12379 issue: 37 year: 2014 ident: 1064_CR156 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1020-13.2014 – volume: 7 start-page: E421 issue: 2 year: 2008 ident: 1064_CR200 publication-title: AAPS J doi: 10.1208/aapsj070242 – volume: 15 start-page: 41 issue: 1 year: 2020 ident: 1064_CR127 publication-title: Neural Regen Res doi: 10.4103/1673-5374.264445 – volume: 37 start-page: 365 issue: 4 year: 2017 ident: 1064_CR167 publication-title: Cephalalgia doi: 10.1177/0333102416646760 – volume: 326 start-page: 113165 year: 2020 ident: 1064_CR37 publication-title: Exp Neurol doi: 10.1016/j.expneurol.2019.113165 – volume: 18 start-page: 507 year: 2007 ident: 1064_CR191 publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e3282ee2a91 – volume: 23 start-page: 187 issue: 3 year: 2018 ident: 1064_CR177 publication-title: CNS Spectr doi: 10.1017/S1092852918001013 – volume: 54 start-page: 266 year: 2007 ident: 1064_CR95 publication-title: Dan Med Bull – volume: 721 start-page: 134783 year: 2020 ident: 1064_CR183 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2020.134783 – volume: 23 start-page: 447 year: 2018 ident: 1064_CR14 publication-title: Paediatr Child Health doi: 10.1093/pch/pxy109 – volume: 189 start-page: 155 year: 2006 ident: 1064_CR64 publication-title: Psychopharmacology doi: 10.1007/s00213-006-0543-8 – volume: 61 start-page: 421 year: 2011 ident: 1064_CR100 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2011.03.022 – volume: 15 start-page: 107985 issue: 168 year: 2020 ident: 1064_CR1 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2020.107985 – volume: 277 start-page: 146 year: 2015 ident: 1064_CR132 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2014.04.007 – volume: 25 start-page: 363 year: 2005 ident: 1064_CR2 publication-title: Biosci Rep doi: 10.1007/s10540-005-2896-3 – year: 2020 ident: 1064_CR74 publication-title: Neuropsychopharmacology doi: 10.1038/s41386-020-0723-y – volume: 161 start-page: 739 issue: 4 year: 2004 ident: 1064_CR40 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.161.4.739 – volume: 12 start-page: e0179934 issue: 6 year: 2017 ident: 1064_CR19 publication-title: PLoS ONE doi: 10.1371/journal.pone.0179934 – volume: 212 start-page: 164 year: 2013 ident: 1064_CR96 publication-title: Psychiatry Res doi: 10.1016/j.pscychresns.2013.02.001 – volume: 38 start-page: 252 issue: 2 year: 2012 ident: 1064_CR185 publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2012.04.008 – volume: 135 start-page: 2358 year: 2012 ident: 1064_CR12 publication-title: Brain doi: 10.1093/brain/aws176 – volume: 213 start-page: 265 year: 2011 ident: 1064_CR30 publication-title: Psychopharmacology doi: 10.1007/s00213-010-2097-z – volume: 64 start-page: 311 year: 2016 ident: 1064_CR72 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2016.03.001 – volume: 25 start-page: 6460 year: 2005 ident: 1064_CR91 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5261-04.2005 – volume: 6 start-page: 571 year: 2013 ident: 1064_CR141 publication-title: Autism Res doi: 10.1002/aur.1317 – volume: 21 start-page: 1 issue: 1 year: 2020 ident: 1064_CR84 publication-title: J Headache Pain doi: 10.1186/s10194-020-01138-x – ident: 1064_CR205 – volume: 595 start-page: 4141 issue: 13 year: 2017 ident: 1064_CR109 publication-title: J Physiol doi: 10.1113/JP273355 – volume: 64 start-page: 317 year: 2012 ident: 1064_CR170 publication-title: J Pharm Pharmacol doi: 10.1111/j.2042-7158.2011.01384.x – volume: 107 start-page: 206 issue: 2–3 year: 2009 ident: 1064_CR3 publication-title: Schizophrenia research Schizophr Res doi: 10.1016/j.schres.2008.08.004 – volume: 5 start-page: 553 year: 1814 ident: 1064_CR58 publication-title: Biochimica et Biophysica Acta BBA-Proteins and Proteomics doi: 10.1016/j.bbapap.2011.02.008 – volume: 194 start-page: 73 issue: 1 year: 2007 ident: 1064_CR97 publication-title: Psychopharmacology doi: 10.1007/s00213-007-0826-8 – volume: 27 start-page: 703 year: 2013 ident: 1064_CR31 publication-title: CNS Drugs doi: 10.1007/s40263-013-0071-0 – volume: 113 start-page: 5429 issue: 19 year: 2016 ident: 1064_CR68 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1522754113 – volume: 492 start-page: 169 issue: 2–3 year: 2004 ident: 1064_CR145 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2004.03.063 |
SSID | ssj0009005 |
Score | 2.6678367 |
SecondaryResourceType | review_article |
Snippet | The serotonergic system extends throughout the central nervous system (CNS) and the gastrointestinal (GI) tract. In the CNS, serotonin (5-HT,... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1671 |
SubjectTerms | Autism Biomedical and Life Sciences Biomedicine Cell Biology Central nervous system Cognition Gastrointestinal tract Humans Mental disorders Mental Disorders - metabolism Molecular modelling Mood Neurobiology Neurosciences Receptors, Serotonin - metabolism Reinforcement Review Paper Schizophrenia Serotonin Serotonin - metabolism |
Title | The Roles of Serotonin in Neuropsychiatric Disorders |
URI | https://link.springer.com/article/10.1007/s10571-021-01064-9 https://www.ncbi.nlm.nih.gov/pubmed/33651238 https://www.proquest.com/docview/2681849129 https://www.proquest.com/docview/2495401427 https://pubmed.ncbi.nlm.nih.gov/PMC11421740 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3PT4MwFH7R7eLFqPMHOk1NjBclGY9C4biYzUWjB-OSeSJQSlyiYNx28L_3tQPmnJqYcKNA6Wv7vq997yvAmeOnmEiUtsQwtnnIhZ2gyGwvcRXBXeoksd7Rvbv3B0N-M_JGZVLYpIp2r7YkzUz9JdnNE0R9UdNfcqR2uA5Nj7i7PrBhiN2F1G5nHriIQucD8U6ZKvPzO5bd0QrGXA2V_LZfatxQfws2S_zIunODb8Oayneg1c2JO79-sHNmIjrNUnkLOPUB9qAVm1iRMZoViqlefGV0GU2OOtJ5LFmlwjnZhWG_93g1sMtTEmzpcWdqh4HnSxpIiDFmBC_QST1HuMpJBI9dHT0aysBRGfHgRJD770iFUhBqwiwM_DR296CRF7k6AJaSt1aYEMvJOM9QC0VxFfiek6UEa2VggVM1ViRLCXF9ksVLtBA_1g0cUQNHpoGj0IKL-pm3uYDGn6XblQ2icjBNIvR1RUJCJhac1rdpGOi9jThXxYzKENEjqshRWLA_N1n9OdelXyBoYkGwZMy6gJbYXr6Tj5-N1LbONCbO1rHgsrL7ol6__8bh_4ofwQbqrAoTV9iGxvR9po4J60yTE2h2r59ueyemi38CovzzIg |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT8MwDLZgHOCCeFMYECTEBSqtbtq0xwmBBmwc0CZxq9o0FZOgQ6w78O9xsrZjDJCQekvaJrYT27H9BeDM8VNMJEpbYhjbPOTCTlBktpe4isxdEpJYR3R7D35nwO-evKeyKGxcZbtXIUmzU38pdvMEub6o3V9SpHa4DCtcaxyS4gG2Z1C7rWniIgpdD8RbZanMz9-YV0cLNuZiquS3eKlRQzcbsF7aj6w9ZfgmLKl8C7bbOfnOrx_snJmMTnNUvg2cZIA9asQmNsoY7QqjQh--MnoMJked6TyUrELhHO_A4Oa6f9Wxy1sSbOlxp7DDwPMlLSTEGDMyL9BJPUe4ykkEj12dPRrKwFEZ-cGJIPXfkgqlIKsJszDw09jdhUY-ytU-sJS0tcKEvJyM8ww1UBRXge85WUpmrQwscCpiRbKEENc3WbxEM_BjTeCICBwZAkehBRf1O29TAI0_ezcrHkTlYhpH6OuBhGSZWHBaN9My0LGNOFejCfUhR49cRY7Cgr0py-rfuS5NgQTFgmCOmXUHDbE935IPnw3Utq40Jp-tZcFlxffZuH6fxsH_up_Aaqff60bd24f7Q1hDXWFhcgyb0CjeJ-qI7J4iOTZi_gmeH_SB |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB6VrVRxQbwbWMCVKi4lYj1x4uS4AlbbQlGFutLeosSxBVLJIggH_j1j57EslEqVcvMksT225xt75jPAVx4VmCtUvsIk80UipJ-jNH6YB5rgLg2SzJ7o_ryMxhPxYxpOX2Txu2j39kiyzmmwLE1ldXxXmOMXiW-hJDcYrStMRtVPluAjLcfc3mEwweGcdndQBzGitLlBYtCkzfz9G4um6Q3efBs2-ers1Jmk0SqsNFiSDWvlr8EHXa7DxrAkP_r2iR0yF93pts03QNB4YFeWvYnNDKMVYlbZjVhGj-Pn6KKebxRrGTkfNmEyOvt9MvabGxN8FQpe-UkcRoomFWKGhqAG8iLkMtA8lyILbCRpomKuDfnEuSQoMFAalSQEhSaJoyILtqBXzkr9GVhBlltjTh6PEcKgJY0SOo5CbgqCuCr2gLedlaqGTtzeavEnnRMh2w5OqYNT18Fp4sG37p27mkzjn9L9VgdpM7EeUoxsRRJCKR586YppSthzjqzUs0eSIaeP3EaB0oPtWmXd74KAmkAwxYN4QZmdgKXbXiwpb64d7bbNOib_beDBUav3eb3eb8bO_4kfwKdfp6P04vvl-S4so022cOGGfehV9496jyBQle-7Uf4M2Ur4vQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Roles+of+Serotonin+in+Neuropsychiatric+Disorders&rft.jtitle=Cellular+and+molecular+neurobiology&rft.au=Pourhamzeh%2C+Mahsa&rft.au=Moravej%2C+Fahimeh+Ghasemi&rft.au=Arabi%2C+Mehrnoosh&rft.au=Shahriari%2C+Elahe&rft.date=2022-08-01&rft.pub=Springer+US&rft.issn=0272-4340&rft.eissn=1573-6830&rft.volume=42&rft.issue=6&rft.spage=1671&rft.epage=1692&rft_id=info:doi/10.1007%2Fs10571-021-01064-9&rft_id=info%3Apmid%2F33651238&rft.externalDocID=PMC11421740 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0272-4340&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0272-4340&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0272-4340&client=summon |